New! View global litigation for patent families

US7858000B2 - Method of making silicone hydrogel contact lenses - Google Patents

Method of making silicone hydrogel contact lenses Download PDF

Info

Publication number
US7858000B2
US7858000B2 US11810601 US81060107A US7858000B2 US 7858000 B2 US7858000 B2 US 7858000B2 US 11810601 US11810601 US 11810601 US 81060107 A US81060107 A US 81060107A US 7858000 B2 US7858000 B2 US 7858000B2
Authority
US
Grant status
Grant
Patent type
Prior art keywords
lens
coating
material
contact
silicone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US11810601
Other versions
US20080174035A1 (en )
Inventor
Lynn Cook Winterton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE, IN GENERAL
    • B29DPRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00Producing optical elements, e.g. lenses or prisms
    • B29D11/00865Applying coatings; tinting; colouring
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE, IN GENERAL
    • B29DPRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00Producing optical elements, e.g. lenses or prisms
    • B29D11/00009Production of simple or compound lenses
    • B29D11/00038Production of contact lenses
    • B29D11/00076Production of contact lenses enabling passage of fluids, e.g. oxygen, tears, between the area under the lens and the lens exterior
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS, OR APPARATUS
    • G02B1/00Optical elements characterised by the material of which they are made
    • G02B1/04Optical elements characterised by the material of which they are made made of organic materials, e.g. plastics
    • G02B1/041Lenses
    • G02B1/043Contact lenses

Abstract

The invention provides a cost-effective method for making a silicone hydrogel contact lens which has a good wettable coating with a good durability.

Description

This application claims the benefits under 35 USC 119(e) of the U.S. Provisional Patent Application No. 60/811,949 filed Jun. 8, 2006 herein incorporated by reference in its entirety.

The present invention is related to methods for making silicone hydrogel lenses with wettable and durable coating. The invention is also related to silicone hydrogel contact lenses with wettable and durable coating.

BACKGROUND OF THE INVENTION

In recent years, soft silicone hydrogel contact lenses, for example, Focus NIGHT & DAY™ and O2OPTIX™ (CIBA VISION), and PureVision™ (Bausch & Lomb) become more and more popular because of their high oxygen permeability and comfort. “Soft” contact lenses conform closely to the shape of the eye, so oxygen cannot easily circumvent the lens. Soft contact lenses must allow oxygen from the surrounding air (i.e., oxygen) to reach the cornea because the cornea does not receive oxygen from the blood supply like other tissue. If sufficient oxygen does not reach the cornea, corneal swelling occurs. Extended periods of oxygen deprivation cause the undesirable growth of blood vessels in the cornea. By having high oxygen permeability, a silicone hydrogel contact lens allows sufficient oxygen permeate through the lens to the cornea and to have minimal adverse effects on corneal health.

However, a silicone hydrogel material typically has a surface or at least some areas of its surface which is hydrophobic (non-wettable). Hydrophobic surface or surface areas will up take lipids or proteins from the ocular environment and may adhere to the eye. Thus, a silicone hydrogel contact lens will generally require a surface modification.

A known method for modifying the hydrophilicity of a relatively hydrophobic contact lens material is through the use of a plasma treatment, for example, commercial lenses such as Focus NIGHT & DAY™ and O2OPTIX™ (CIBA VISION), and PureVision™ (Bausch & Lomb). Advantages of a plasma coating is its durability, relatively high hydrophilicity (or good wettability), and low susceptibility to lipid and protein deposition and adsorption. But, plasma treatment of silicone hydrogel contact lenses may not be cost effective, because the preformed contact lenses must be dried before plasma treatment and because of relative high capital investment associated with plasma treatment equipments.

Another method for modifying the hydrophilicity of a relatively hydrophobic contact lens material is a layer-by-layer (LbL) polyionic material deposition technique (see for example, U.S. Pat. Nos. 6,451,871, 6,717,929, 6,793,973, 6,884,457, 6,896,926, 6,926,965, 6,940,580). This technique can provide a cost effective process for rendering a silicone hydrogel material wettable. However, such LbL coating may be less durable than a plasma coating for extended wear purpose.

Another method for modifying the surface hydrophilicity of a silicone hydrogel contact lens is the incorporation of wetting agents into a lens formulation for making the silicone hydrogel contact lens as proposed in U.S. Pat. Nos. 6,367,929 and 6,822,016. This method may be cost effective because after cast-molding of silicone hydrogel contact lenses there is no additional posterior process required for modifying the surface hydrophilicity of the lens. However, the wetting agents may not stay effective over time and may not provide a durable wettable surface. In addition, there may be hydrophobic surface spots which can be extremely susceptible to lipid/protein adsorption and deposition.

Therefore, there is a need for a method of producing silicone hydrogel contact lenses with wettable and durable coating (surface) in a cost effective manner.

SUMMARY OF THE INVENTION

The present invention provides a method for making a silicone hydrogel contact lens, the method comprising the steps of: (a) obtaining a mold having a first mold half and a second mold half, wherein the first mold half includes a first molding surface and the second mold half includes a second molding surface, wherein the first and second mold halves are configured to receive each other such that a lens-forming cavity is formed between the first molding surface and the second molding surface; (b) applying a first transferable LbL coating to the first molding surface and a second transferable LbL coating to the second molding surface, wherein each of the first and second transferable LbL coatings comprises at least one layer of a first polyionic polymeric material and optionally at least one layer of a second polyionic material or a non-charged hydrophilic polymer with a hydrophobic backbone, wherein the first and second polyionic material each have a hydrophobic backbone and multiple ionizable or charged pendant groups, wherein the first and second polyionic materials have charges opposite to each other; (c) dispensing a silicone hydrogel lens-forming fluid material into the lens-forming cavity of the mold with the first and second transferable LbL coatings on their molding surfaces, wherein the silicone-hydrogel lens-forming material comprises a non-crosslinkable hydrophilic polymer and at least one member selected from the group consisting of a silicone-containing vinylic monomer, a silicone-containing macromer with ethylenically unsaturated groups, a crosslinkable silicone-containing prepolymer, and mixtures thereof, wherein the non-crosslinkable hydrophilic polymer is capable of forming an interfacial film at interface between the coated molding surfaces and the lens-forming fluid material; (d) soaking the transferable LbL coatings with the lens-forming fluid material for a time period sufficient both to allow the non-crosslinkable hydrophilic polymer in the interface film penetrate into the transferable LbL coatings and to entangle with coating materials in the transferable LbL coatings; and (e) curing the lens-forming material within the lens-forming cavity to form the silicone hydrogel contact lens, whereby the transferable LbL coatings detach from the molding surfaces and reattaches to the formed silicone hydrogel contact lens such that said silicone hydrogel contact lens becomes coated with the transferable LbL coatings, wherein the non-crosslinkable hydrophilic polymer has a molecular weight or structure that promotes entanglement of the non-crosslinkable hydrophilic polymer in the interfacial film with the polymer matrix of the formed lens so as to obtain a wettable surface coating with a good coating durability characterized by surviving at least five consecutive digital rubbing tests.

The present invention also provides a method for making a silicone hydrogel contact lens, the method comprising the steps of: (a) obtaining a mold having a first mold half and a second mold half, wherein the first mold half includes a first molding surface and the second mold half includes a second molding surface, wherein the first and second mold halves are configured to receive each other such that a lens-forming cavity is formed between the first molding surface and the second molding surface; (b) applying a first transferable LbL coating to the first molding surface and a second transferable LbL coating to the second molding surface, wherein each of the first and second transferable LbL coatings comprises at least one layer of a first polyionic polymeric material and optionally at least one layer of a second polyionic material or a non-charged hydrophilic polymer with a hydrophobic backbone, wherein the first and second polyionic material each have a hydrophobic backbone and multiple ionizable or charged pendant groups, wherein the first and second polyionic materials have charges opposite to each other; (c) dispensing a silicone hydrogel lens-forming fluid material into the lens-forming cavity of the mold with the first and second transferable LbL coatings on their molding surfaces, wherein the silicone-hydrogel lens-forming material comprises a non-crosslinkable hydrophilic polymer and at least one member selected from the group consisting of a silicone-containing vinylic monomer, a silicone-containing macromer with ethylenically unsaturated groups, a crosslinkable silicone-containing prepolymer, and mixtures thereof, wherein the non-crosslinkable hydrophilic polymer is capable of forming an interfacial film at interface between the coated molding surfaces and the lens-forming fluid material; (d) soaking the transferable LbL coatings with the lens-forming fluid material for a time period sufficient both to allow the non-crosslinkable hydrophilic polymer in the interface film penetrate into the transferable LbL coatings and to entangle with coating materials in the transferable LbL coatings; and (e) curing the lens-forming material within the lens-forming cavity to form the silicone hydrogel contact lens, whereby the transferable LbL coatings detach from the molding surfaces and reattaches to the formed silicone hydrogel contact lens such that said silicone hydrogel contact lens becomes coated with the transferable LbL coatings, wherein the non-crosslinkable hydrophilic polymer has a molecular weight or structure that promotes entanglement of the non-crosslinkable hydrophilic polymer in the interfacial film with the polymer matrix of the formed lens so as to obtain a wettable surface coating with a good coating durability characterized by surviving at least five consecutive digital rubbing tests.

This and other aspects of the invention will become apparent from the following description of the presently preferred embodiments. The detailed description is merely illustrative of the invention and does not limit the scope of the invention, which is defined by the appended claims and equivalents thereof. As would be obvious to one skilled in the art, many variations and modifications of the invention may be effected without departing from the spirit and scope of the novel concepts of the disclosure.

DETAILED DESCRIPTION OF EMBODIMENTS OF THE INVENTION

Reference now will be made in detail to the embodiments of the invention. It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the scope or spirit of the invention. For instance, features illustrated or described as part of one embodiment, can be used on another embodiment to yield a still further embodiment. Thus, it is intended that the present invention cover such modifications and variations as come within the scope of the appended claims and their equivalents. Other objects, features and aspects of the present invention are disclosed in or are obvious from the following detailed description. It is to be understood by one of ordinary skill in the art that the present discussion is a description of exemplary embodiments only, and is not intended as limiting the broader aspects of the present invention.

Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Generally, the nomenclature used herein and the laboratory procedures are well known and commonly employed in the art. Conventional methods are used for these procedures, such as those provided in the art and various general references. Where a term is provided in the singular, the inventors also contemplate the plural of that term. The nomenclature used herein and the laboratory procedures described below are those well known and commonly employed in the art.

“Contact Lens” refers to a structure that can be placed on or within a wearer's eye. A contact lens can correct, improve, or alter a user's eyesight, but that need not be the case. A contact lens can be of any appropriate material known in the art or later developed, and can be a soft lens, a hard lens, or a hybrid lens. A “silicone hydrogel contact lens” refers to a contact lens comprising a silicone hydrogel material.

The “front or anterior surface” of a contact lens, as used herein, refers to the surface of the lens that faces away from the eye during wear. The anterior surface, which is typically substantially convex, may also be referred to as the front curve of the lens.

The “rear or posterior surface” of a contact lens, as used herein, refers to the surface of the lens that faces towards the eye during wear. The rear surface, which is typically substantially concave, may also be referred to as the base curve of the lens.

A “hydrogel” refers to a polymeric material which can absorb at least 10 percent by weight of water when it is fully hydrated.

A “silicone hydrogel” refers to a silicone-containing hydrogel obtained by copolymerization of a polymerizable composition comprising at least one silicone-containing vinylic monomer or at least one silicone-containing macromer or at least one crosslinkable silicone-containing prepolymer.

“Hydrophilic,” as used herein, describes a material or portion thereof that will more readily associate with water than with lipids.

A “monomer” means a low molecular weight compound that can be polymerized. Low molecular weight typically means average molecular weights less than 700 Daltons.

A “vinylic monomer”, as used herein, refers to a low molecular weight compound that has an ethylenically unsaturated group and can be polymerized actinically or thermally. Low molecular weight typically means average molecular weights less than 700 Daltons.

The term “olefinically unsaturated group” or “ethylenticaly unsaturated group” is employed herein in a broad sense and is intended to encompass any groups containing at least one >C═C< group. Exemplary ethylenically unsaturated groups include without limitation acryloyl, methacryloyl, allyl, vinyl, styrenyl, or other C═C containing groups.

As used herein, “actinically” in reference to curing or polymerizing of a polymerizable composition or material means that the curing (e.g., crosslinked and/or polymerized) is performed by actinic irradiation, such as, for example, UV irradiation, ionized radiation (e.g. gamma ray or X-ray irradiation), microwave irradiation, and the like. Thermal curing or actinic curing methods are well-known to a person skilled in the art.

A “hydrophilic vinylic monomer”, as used herein, refers to a vinylic monomer which as a homopolymer typically yields a polymer that is water-soluble or can absorb at least 10 percent by weight water.

A “hydrophobic vinylic monomer”, as used herein, refers to a vinylic monomer which as a homopolymer typically yields a polymer that is insoluble in water and can absorb less than 10 percent by weight water.

A “macromer” refers to a medium and high molecular weight compound or polymer that contains ethylenically unsaturated groups capable of undergoing further polymerizing and/or crosslinking reactions. Medium and high molecular weight typically means average molecular weights greater than 700 Daltons. Preferably, a macromer contains ethylenically unsaturated groups and can be polymerized actinically or thermally.

A “prepolymer” refers to a starting polymer which contains ethylenically unsaturated groups and can be cured (e.g., crosslinked and/or polymerized) actinically or thermally to obtain a crosslinked and/or polymerized polymer having a molecular weight much higher than the starting polymer.

A “silicone-containing prepolymer” refers to a prepolymer which contains silicone and can be crosslinked upon actinic radiation or thermally to obtain a crosslinked polymer having a molecular weight much higher than the starting polymer.

A “polymer” means a material formed by polymerizing/crosslinking one or more monomers.

A “photoinitiator” refers to a chemical that initiates radical crosslinking/polymerizing reaction by the use of light. Suitable photoinitiators include, without limitation, benzoin methyl ether, diethoxyacetophenone, a benzoylphosphine oxide, 1-hydroxycyclohexyl phenyl ketone, Darocure® types, and Irgacure® types, preferably Darocure® 1173, and Irgacure® 2959.

A “thermal initiator” refers to a chemical that initiates radical crosslinking/polymerizing reaction by the use of heat energy. Examples of suitable thermal initiators include, but are not limited to, 2,2′-azobis(2,4-dimethylpentanenitrile), 2,2′-azobis(2-methylpropanenitrile), 2,2′-azobis (2-methylbutanenitrile), peroxides such as benzoyl peroxide, and the like. Preferably, the thermal initiator is 2,2′-azobis(isobutyronitrile) (AIBN).

An “interpenetrating polymer network (IPN)” as used herein refers broadly to an intimate network of two or more polymers at least one of which is either synthesized and/or crosslinked in the presence of the other(s). Techniques for preparing IPN are known to one skilled in the art. For a general procedure, see U.S. Pat. Nos. 4,536,554, 4,983,702, 5,087,392, and 5,656,210, the contents of which are all incorporated herein by reference. The polymerization is generally carried out at temperatures ranging from about room temperature to about 145° C.

A “spatial limitation of actinic radiation” refers to an act or process in which energy radiation in the form of rays is directed by means of, for example, a mask or screen or combinations thereof, to impinge, in a spatially restricted manner, onto an area having a well defined peripheral boundary. For example, a spatial limitation of UV radiation can be achieved by using a mask or screen which has a transparent or open region (unmasked region) surrounded by a UV impermeable region (masked region), as schematically illustrated in FIGS. 1-9 of U.S. Pat. No. 6,627,124 (herein incorporated by reference in its entirety). The unmasked region has a well defined peripheral boundary with the unmasked region.

“Visibility tinting” in reference to a lens means dying (or coloring) of a lens to enable the user to easily locate a lens in a clear solution within a lens storage, disinfecting or cleaning container. It is well known in the art that a dye and/or a pigment can be used in visibility tinting a lens.

“Dye” means a substance that is soluble in a solvent and that is used to impart color. Dyes are typically translucent and absorb but do not scatter light. Any suitable biocompatible dye can be used in the present invention.

A “Pigment” means a powdered substance that is suspended in a liquid in which it is insoluble. A pigment can be a fluorescent pigment, phosphorescent pigment, pearlescent pigment, or conventional pigment. While any suitable pigment may be employed, it is presently preferred that the pigment be heat resistant, non-toxic and insoluble in aqueous solutions.

The term “fluid” as used herein indicates that a material is capable of flowing like a liquid.

“LbL coating”, as used herein, refers to a coating that is not covalently attached to a contact lens or a mold half and is obtained through a layer-by-layer (“LbL”) deposition of polyionic (or charged) and/or non-charged materials on the lens or mold half. An LbL coating can be composed of one or more layers, preferably one or more bilayers.

As used herein, a “polyionic material” refers to a polymeric material that has a plurality of charged groups or ionizable groups, such as polyelectrolytes, p- and n-type doped conducting polymers. Polyionic materials include both polycationic (having positive charges) and polyanionic (having negative charges) materials.

The term “bilayer” is employed herein in a broad sense and is intended to encompass: a coating structure formed on a contact lens or a mold half by alternatively applying, in no particular order, one layer of a first polyionic material (or charged material) and subsequently one layer of a second polyionic material (or charged material) having charges opposite of the charges of the first polyionic material (or the charged material); or a coating structure formed on a contact lens or mold half by alternatively applying, in no particular order, one layer of a first charged polymeric material and one layer of a non-charged polymeric material or a second charged polymeric material. It should be understood that the layers of the first and second coating materials (described above) may be intertwined with each other in the bilayer.

Formation of an LbL coating on a contact lens or mold half may be accomplished in a number of ways, for example, as described in U.S. Pat. Nos. 6,451,871, 6,719,929, 6,793,973, 6,811,805, 6,896,926 (herein incorporated by references in their entirety).

An “innermost layer”, as used herein, refers to the first layer of an LbL coating, which is applied onto the surface of a contact lens or mold half.

A “capping layer” or “outmost layer”, as used herein, refers to the last layer or the sole layer of an LbL coating which is applied onto a contact lens or mold half.

An “average contact angle” refers to a water contact angle (advancing angle measured by Wilhelmy Plate method), which is obtained by averaging measurements of at least 3 individual contact lenses.

As used herein, “increased surface hydrophilicity” or “increased hydrophilicity” in reference to a coated contact lens means that the coated contact lens has a reduced averaged contact angle relative to an uncoated contact lens, wherein both coated and uncoated contact lens are made of the same core material.

As used herein, “surviving a digital rubbing test” in reference to a coating on a contact lens means that after digitally rubbing the lens with Solo-care® (CIBA Vision) or an equivalent, there is no noticeable increase in staining area on the lens relative to the staining of a lens of same without rubbing, as described in Example 1. In accordance with the invention, a silicone hydrogel contact lens of the invention has a coating that is capable of surviving at least 5, preferably at least 10, more preferably at least 20, even more preferably at least 25 consecutive digital rubbing tests.

An “antimicrobial agent”, as used herein, refers to a chemical that is capable of decreasing or eliminating or inhibiting the growth of microorganisms such as that term is known in the art.

“Antimicrobial metals” are metals whose ions have an antimicrobial effect and which are biocompatible. Preferred antimicrobial metals include Ag, Au, Pt, Pd, Ir, Sn, Cu, Sb, Bi and Zn, with Ag being most preferred.

“Antimicrobial metal-containing nanoparticles” refer to particles having a size of less than 1 micrometer and containing at least one antimicrobial metal present in one or more of its oxidation states.

“Antimicrobial metal nanoparticles” refer to particles which is made essentially of an antimicrobial metal and have a size of less than 1 micrometer. The antimicrobial metal in the antimicrobial metal nanoparticles can be present in one or more of its oxidation states. For example, silver-containing nanoparticles can contain silver in one or more of its oxidation states, such as Ag0, Ag1+, and Ag2+.

“Stabilized antimicrobial metal nanoparticles” refer to antimicrobial metal nanoparticles which are stabilized by a stabilizer during their preparation. Stabilized antimicrobial metal nano-particles can be either positively charged or negatively charged or neutral, largely depending on a material (or so-called stabilizer) which is present in a solution for preparing the nano-particles and can stabilize the resultant nano-particles. A stabilizer can be any known suitable material. Exemplary stabilizers include, without limitation, positively charged polyionic materials, negatively charged polyionic materials, polymers, surfactants, salicylic acid, alcohols and the like.

The “oxygen transmissibility” of a lens, as used herein, is the rate at which oxygen will pass through a specific ophthalmic lens. Oxygen transmissibility, Dk/t, is conventionally expressed in units of barrers/mm, where t is the average thickness of the material [in units of mm] over the area being measured and “barrer/mm” is defined as:
[(cm3oxygen)/(cm2)(sec)(mm2Hg)]×10−9

The intrinsic “oxygen permeability”, Dk, of a lens material does not depend on lens thickness. Intrinsic oxygen permeability is the rate at which oxygen will pass through a material. Oxygen permeability is conventionally expressed in units of barrers, where “barrer” is defined as:
[(cm3oxygen)(mm)/(cm2)(sec)(mm2Hg)]×10−10
These are the units commonly used in the art. Thus, in order to be consistent with the use in the art, the unit “barrer” will have the meanings as defined above. For example, a lens having a Dk of 90 barrers (“oxygen permeability barrers”) and a thickness of 90 microns (0.090 mm) would have a Dk/t of 100 barrers/mm (oxygen transmissibility barrers/mm). In accordance with the invention, a high oxygen permeability in reference to a material or a contact lens characterized by apparent oxygen permeability of at least 40 barrers or larger measured with a sample (film or lens) of 100 microns in thickness according to a coulometric method described in Examples.

The “ion permeability” through a lens correlates with both the Ionoflux Diffusion Coefficient and the Ionoton Ion Permeability Coefficient.

The Ionoflux Diffusion Coefficient, D, is determined by applying Fick's law as follows:
D=−n′/(A×dc/dx)
where

n′=rate of ion transport [mol/min]

A=area of lens exposed [mm2]

D=Ionoflux Diffusion Coefficient [mm2/min]

dc=concentration difference [mol/L]

dx=thickness of lens [mm]

The Ionoton Ion Permeability Coefficient, P, is then determined in accordance with the following equation:
In(1−2C(t)/C(0))=−2APt/Vd
where:

C(t)=concentration of sodium ions at time t in the receiving cell

C(0)=initial concentration of sodium ions in donor cell

A=membrane area, i.e., lens area exposed to cells

V=volume of cell compartment (3.0 ml)

d=average lens thickness in the area exposed

P=permeability coefficient

An Ionoflux Diffusion Coefficient, D, of greater than about 1.5×10−6 mm2/min is preferred, while greater than about 2.6×10−6 mm2/min is more preferred and greater than about 6.4×10−6 mm2/min is most preferred.

It is known that on-eye movement of the lens is required to ensure good tear exchange, and ultimately, to ensure good corneal health. Ion permeability is one of the predictors of on-eye movement, because the permeability of ions is believed to be directly proportional to the permeability of water.

The term “oxyperm component in a polymerizable composition” as used herein, refers to monomers, oligomers, macromers, and the like, and mixtures thereof, which are capable of polymerizing with like or unlike polymerizable materials to form a polymer which displays a relatively high rate of oxygen diffusion therethrough.

In general, the invention is directed to a cost-effective method for making silicone hydrogel contact lenses with durable hydrophilic coatings. The invention is partly based on the discovery that by first forming a transferable LbL coating on the molding surfaces of a mold for making a silicone hydrogel contact lens and then by incorporate a selected non-crosslinkable hydrophilic polymer in a silicone hydrogel lens-forming fluid composition, a silicone hydrogel contact lens with a durable coating can be obtained by cast molding without surface treatment posterior to cast molding. It is believed that an internal wetting agent (i.e., in the lens-forming material) can form an interfacial film at the interface between a mold with transferable LbL coating and the lens-forming composition therein, prior to curing the lens-forming composition. Wetting agent in this interfacial film may penetrate into the transfer LbL coating and entangle with coating materials in the transferable LbL coating to function as anchors for enforcing the bonding (non-covalently bonding) of the transfer LbL coating to a formed silicone hydrogel lens. The interfacial film of the wetting agent may also improve the intactness of the coating of the resultant lens. It is also believed that molecules of an internal wetting agent in the interfacial film should have significant portion(s) (e.g., relatively long tails or dangling polymer chain segments) of its structure which can extend outwardly from the interfacial film into the lens-forming composition and subsequently can be entrapped within and become entangled with the polymer matrix of a formed lens. Such entrapment and entanglements of the internal wetting agent within the transferable LbL coating and the polymer matrix of the resultant lens may significantly improve the durability of the coating of the resultant silicone hydrogel contact lens.

The present invention also provides a method for making a silicone hydrogel contact lens, the method comprising the steps of: (a) obtaining a mold having a first mold half and a second mold half, wherein the first mold half includes a first molding surface and the second mold half includes a second molding surface, wherein the first and second mold halves are configured to receive each other such that a lens-forming cavity is formed between the first molding surface and the second molding surface; (b) applying a first transferable LbL coating to the first molding surface and a second transferable LbL coating to the second molding surface, wherein each of the first and second transferable LbL coatings comprises at least one layer of a first polyionic polymeric material and optionally at least one layer of a second polyionic material or a non-charged hydrophilic polymer with a hydrophobic backbone, wherein the first and second polyionic material each have a hydrophobic backbone and multiple ionizable or charged pendant groups, wherein the first and second polyionic materials have charges opposite to each other; (c) dispensing a silicone hydrogel lens-forming fluid material into the lens-forming cavity of the mold with the first and second transferable LbL coatings on their molding surfaces, wherein the silicone-hydrogel lens-forming material comprises a non-crosslinkable hydrophilic polymer and at least one member selected from the group consisting of a silicone-containing vinylic monomer, a silicone-containing macromer with ethylenically unsaturated groups, a crosslinkable silicone-containing prepolymer, and mixtures thereof, wherein the non-crosslinkable hydrophilic polymer is capable of forming an interfacial film at interface between the coated molding surfaces and the lens-forming fluid material; (d) soaking the transferable LbL coatings with the lens-forming fluid material for a time period sufficient both to allow the non-crosslinkable hydrophilic polymer in the interface film penetrate into the transferable LbL coatings and to entangle with coating materials in the transferable LbL coatings; and (e) curing the lens-forming material within the lens-forming cavity to form the silicone hydrogel contact lens, whereby the transferable LbL coatings detach from the molding surfaces and reattaches to the formed silicone hydrogel contact lens such that said silicone hydrogel contact lens becomes coated with the transferable LbL coatings, wherein the non-crosslinkable hydrophilic polymer has a molecular weight or structure that promotes entanglement of the non-crosslinkable hydrophilic polymer in the interfacial film with the polymer matrix of the formed lens so as to obtain a wettable surface coating with a good coating durability characterized by surviving at least five consecutive digital rubbing tests.

Lens molds for making contact lenses are well known to a person skilled in the art and, for example, are employed in cast molding or spin casting. For example, a mold (for cast molding) generally comprises at least two mold sections (or portions) or mold halves, i.e. first and second mold halves. The first mold half defines a first molding (or optical) surface and the second mold half defines a second molding (or optical) surface. The first and second mold halves are configured to receive each other such that a lens forming cavity is formed between the first molding surface and the second molding surface. The molding surface of a mold half is the cavity-forming surface of the mold and in direct contact with lens-forming material.

Methods of manufacturing mold sections for cast-molding a contact lens are generally well known to those of ordinary skill in the art. The process of the present invention is not limited to any particular method of forming a mold. In fact, any method of forming a mold can be used in the present invention. The first and second mold halves can be formed through various techniques, such as injection molding or lathing. Examples of suitable processes for forming the mold halves are disclosed in U.S. Pat. No. 4,444,711 to Schad; U.S. Pat. No. 4,460,534 to Boehm et al.; U.S. Pat. No. 5,843,346 to Morrill; and U.S. Pat. No. 5,894,002 to Boneberger et al., which are also incorporated herein by reference.

Virtually all materials known in the art for making molds can be used to make molds for making contact lenses. For example, polymeric materials, such as polyethylene, polypropylene, polystyrene, PMMA, cyclic olefin copolymers (e.g., Topas® COC from Ticona GmbH of Frankfurt, Germany and Summit, N.J.; Zeonex® and Zeonor® from Zeon Chemicals LP, Louisville, Ky.), or the like can be used. Other materials that allow UV light transmission could be used, such as quartz glass and sapphire.

In a preferred embodiment, reusable molds are used and the silicone-hydrogel lens-forming material is cured actinically under a spatial limitation of actinic radiation to form a silicone hydrogel contact lens. Examples of preferred reusable molds are those disclosed in U.S. Patent Application Publication No. US 2004-0178541 A1 and U.S. Pat. Nos. 6,627,124, 6,800,225, which are incorporated by reference in their entireties.

In accordance with the present invention, an LbL coating can be applied to the molding surface of a mold half by contacting the molding surface with one or more coating solutions according to various methods, such as, for examples those methods disclosed in U.S. Pat. Nos. 6,451,871, 6,719,929, 6,793,973, 6,811,805, 6,896,926, which are incorporated herein by references in their entireties.

Contacting of the molding surface of a mold half with a coating solution can occur by dipping it into the coating solution or by spraying it with the coating solution. One coating process involves solely dip-coating and optionally dip-rinsing steps. Another coating process involves solely spray-coating and spray-rinsing steps. However, a number of alternatives involve various combinations of spray- and dip-coating and rinsing steps may be designed by a person having ordinary skill in the art.

For example, a solely dip-coating process for forming an LbL coating composed of at least one bilayers on the molding surface of a mold half involves the steps of: (a) immersing a mold half in a first coating solution of a first coating material; (b) optionally rinsing the mold half by immersing it in a first rinsing solution; (c) immersing the mold half in a second coating solution of a second coating material to form a first bilayer of the first and second coating materials; (d) optionally rinsing the mold half by immersing it in the rinsing solution; and (e) optionally repeating steps (a) to (d) for a number of times to form additional bilayers. A thicker LbL coating can be produced by repeating steps (a) to (d) preferably for 2 to 40 times.

The immersion time for each of the coating and optional rinsing steps may vary depending on a number of factors. Preferably, immersion of the core material into a coating solution occurs over a period of about 1 to 30 minutes, more preferably about 1 to 20 minutes, and most preferably about 1 to 5 minutes. Rinsing may be accomplished with a plurality of rinsing steps, but a single rinsing step, if desired, can be quite efficient.

Another exemplary coating process for forming an LbL coating composed of at least one bilayers on the molding surface of a mold half is a single dip-coating process as described in U.S. Pat. No. 6,793,973. Such single dip-coating process involves dipping a mold half in a solution containing a first coating material and a second coating material in an amount such that the molar charge ratio of said solution is from about 3:1 to about 100:1. Multiple bilayers can be formed on the molding surface of a mold half by using this single dip-coating process.

A further exemplary coating process for forming an LbL coating composed of at least one bilayers on the molding surface of a mold half involves a series of spray coating techniques. For example, a solely spray-coating process generally includes the steps of: (a) spraying the molding surface of a mold half with a first coating solution of a first coating material; (b) optionally rinsing the mold surface by spraying it with a rinsing solution; (c) spraying the molding surface with a second coating solution of a second coating material to form a first bilayer of the first and second coating materials; (d) optionally rinsing the molding surface by spraying it with the rinsing solution; (e) optionally repeating steps (a) to (d) for a number of times. A thicker LbL coating can be produced by repeating steps (a) to (d) preferably for 2 to 40 times.

The spray coating application may be accomplished via a process selected from the group consisting of an air-assisted atomization and dispensing process, an ultrasonic-assisted atomization and dispensing process, a piezoelectric assisted atomization and dispensing process, an electromechanical jet printing process, a piezo-electric jet printing process, a piezo-electric with hydrostatic pressure jet printing process, and a thermal jet printing process; and a computer system capable of controlling the positioning of the dispensing head of the spraying device on the ophthalmic lens and dispensing the coating liquid. Those spraying coating processes are described in U.S. Pat. No. 6,811,805.

In accordance with the invention, coating materials for forming transferable LbL coating include, without limitation, polyionic materials, non-charged polymeric materials, polymerized vesicles (liposomes and micelles) with surface charges, charged antimicrobial metal nanoparticles (preferably charged silver nano-particles), and charged antimicrobial metal-containing nanoparticles (preferably charged silver-containing nanoparticles).

The polyionic materials that may be employed in the present invention include polyanionic and polycationic polymers with a hydrophobic backbone and charged or ionizable pendant groups. Preferably, the polyionic materials are polyanionic polymers.

Examples of suitable polyanionic polymers include, without limitation a linear polyacrylic acid (PAA), a branched polyacrylic acid, a polymethacrylic acid (PMA), a polyacrylic acid or polymethacrylic acid copolymer, a maleic or fumaric acid copolymer, a poly(styrenesulfonic acid) (PSS). Examples of a branched polyacrylic acid include a Carbophil® or Carbopol® type from Goodrich Corp. Examples of a copolymer of acrylic or methacrylic acid include a copolymerization product of an acrylic or methacrylic acid with a vinyl monomer including, for example, acrylamide, N,N-dimethyl acrylamide or N-vinylpyrrolidone. A preferred polyanionic polymer with a hydrophobic backbone is a linear or branched polyacrylic acid or an acrylic acid copolymer. A more preferred anionic polymer is a linear or branched polyacrylic acid. A branched polyacrylic acid in this context is to be understood as meaning a polyacrylic acid obtainable by polymerizing acrylic acid in the presence of suitable (minor) amounts of a di- or multi-vinyl compound.

Examples of polycationic polymers with a hydrophobic backbone include, without limitation, a polyallylamine (PAH), a polyethyleneimine (PEI), a polyvinylamine, a poly(vinylbenzyl-tri-C1-C4-alkylammonium salt), poly(vinylpyridinium salt), polyquat. The above mentioned polymers comprise in each case the free amine, a suitable salt thereof as well as any quaternized form, if not specified otherwise.

Any suitable non-charged hydrophilic polymers with a hydrophobic backbone can be used in the invention. They are preferably polyvinyl alcohols (PVAs), more preferably a homopolymer of a vinyl lactam, a copolymer of at least one vinyl lactam in the presence or in the absence of one or more hydrophilic vinylic comonomers, or mixtures thereof.

PVA is a highly biocompatible material used widely in ophthalmic products, especially wetting drops or artificial tears for ocular comfort (e.g., HypoTears™, etc.). PVAs of all kinds, for example those with low, medium or high polyvinyl acetate contents may be employed. Polyvinyl alcohols employed in the present invention are known and are commercially available, for example under the brand name Mowiol® from KSE (Kuraray Specialties Europe).

In accordance with the invention, the vinyl lactam has a structure of formula (I)

Figure US07858000-20101228-C00001

wherein R is an alkylene di-radical having from 2 to 8 carbon atoms; R1 is hydrogen, alkyl, aryl, aralkyl or alkaryl, preferably hydrogen or lower alkyl having up to 7 carbon atoms, and, more preferably, up to 4 carbon atoms, such as, for example, methyl, ethyl or propyl; aryl having up to 10 carbon atoms, and also aralkyl or alkaryl having up to 14 carbon atoms; and R2 is hydrogen or lower alkyl having up to 7 carob atoms and, more preferably, up to 4 carbon atoms, such as, for example, methyl, ethyl or propyl.

A preferred non-charged hydrophilic polymer is a copolymer derived from a vinyl lactam which is a heterocyclic monomer of formula (I) containing from 4 to 6 carbon atoms in the heterocyclic ring, or a mixture thereof. A more preferred non-charged hydrophilic polymer is a copolymer derived from a vinyl lactam which is a heterocyclic monomer of formula (I) containing 4 carbon atoms in the heterocyclic ring, or a mixture thereof. An even more preferred non-charged hydrophilic polymer is a copolymer derived from a vinyl lactam which is a heterocyclic monomer of formula (I) containing 4 carbon atoms in the heterocyclic ring and wherein R1 and R2 are each independently of the other hydrogen or lower alkyl, or a mixture thereof. A most preferred non-charged hydrophilic polymer is polyvinylpyrrolidone (PVP).

In accordance with the present invention, coating solutions can be prepared in a variety of ways. Preferably, a coating solution can be formed by dissolving a coating material in water. The concentration of a coating material in a solution can generally vary depending on the particular materials being utilized, the desired coating thickness, and a number of other factors. It may be typical to formulate a relatively dilute aqueous solution of a coating material. For example, a coating material concentration can be between about 0.0001% to about 0.25% by weight, between about 0.005% to about 0.10% by weight, or between about 0.01% to about 0.05% by weight.

In order to alter various characteristics of the coating, such as thickness, the molecular weight of the coating materials can be varied. In particular, as the molecular weight is increased, the coating thickness generally increases.

In accordance with the invention, a transferable LbL coating comprises at least one layer of a first polyionic material. The first polyionic material can be any charged materials, such as a polyanionic polymeric material, a polycationic polymeric material, polymerized vesicles with surface charges, charged antimicrobial metal nanoparticles (preferably charged silver nano-particles), charged antimicrobial metal-containing nanoparticles (preferably charged silver-containing nanoparticles), or mixtures thereof. The first polyionic material is preferably a polyanionic polymer or a polycationic polymer.

The transferable LbL coating can further comprises at least one layer of a second coating material, wherein the second coating material can be non-covalently bound to the first polyionic material. The second coating material can be a polyionic material having charges opposite of the first polyionic material or a non-charged polymeric material capable of being bound to the first polyionic material as disclosed in U.S. Pat. No. 6,926,965 (herein incorporated by reference in its entirety). Preferred non-charged polymeric materials include without limitation homopolymers of a vinyl lactam, copolymers of at least one vinyl lactam in the presence or in the absence of one or more hydrophilic vinylic monomers, or mixtures thereof.

In a preferred embodiment, the transferable LbL coating on the molding surface comprises one outmost layer of a polyionic polymeric material.

In another preferred embodiment, the transferable LbL coating on the molding surface comprises at least one bilayer of a polyanionic polymeric material and a polycationic polymeric material.

In another preferred embodiment, the transferable LbL coating on the molding surface comprises at least one bilayer of a polyionic polymeric material and a non-charged polymeric material capable of being non-covalently bound to the polyionic polymeric material.

In another preferred embodiment, the transferable LbL coating on the molding surface comprises at least one layer of a lubricious coating material which is selected from the group consisting of PAMAM dendrimers, PAAm-co-PAA, PVP-co-PAA, glycosaminoglycanes, fucoidan, poly-aspartic acid, poly-glutamic acid, carboxymethyl cellulose, carboxymethyl dextrans, alginates, pectins, gellan, carboxyalkyl chitins, carboxymethyl chitosans, sulfated polysaccharides, glucoproteins, and aminoalkylated polysaccharides.

In a more preferred embodiment, the transferable coating comprises at least one layer of polyacrylic acid (PAA) and at least one layer of polyvinylpyrrolidone.

A transferable LbL coating can comprise two or more bilayers. A preferred number of bilayers in a transferable LbL coating are about 2 to about 20 bilayers. While more than 20 bilayers are possible, it has been found that delamination may occur in some LbL coatings having an excessive number of bilayers. A more preferred number of bilayers is about 2 to about 10 bilayers.

In a preferred embodiment, the first and second transferable LbL coatings are identical to each other.

In another preferred embodiment, the first and second transferable LbL coatings are different from each other. Under such circumstance, a resultant silicone hydrogel contact lens has asymmetrical coatings thereon. As used herein, “asymmetrical coatings” on a contact lens refers to the different coatings on the anterior surface and the opposite posterior surface of the contact lens. As used herein, “different coatings” refers to two coatings that have different compositions. For example, the first transferable LbL coating comprises at least one layer of a polyanionic material and at least one layer of a non-charged hydrophilic polymer with a hydrophobic backbone, whereas the second transferable LbL coating comprises at least one layer of a polyanionic material and at least one layer of a polycationic material. With asymmetrical coatings, a contact lens may have different surface properties and/or functionalities.

A “silicone hydrogel lens-forming material” refers to a polymerizable composition which can be cured (i.e., polymerized and/or crosslinked) thermally or actinically or chemically to obtain a crosslinked silicone-containing polymer. Lens-forming materials are well known to a person skilled in the art. In accordance with the invention, a silicone hydrogel lens-forming material comprises at least one silicon-containing monomer or macromer, or can be any lens formulations for making soft contact lenses. Exemplary lens formulations include without limitation the formulations of lotrafilcon A, lotrafilcon B, etafilcon A, genfilcon A, lenefilcon A, polymacon, acquafilcon A, balafilcon, senofilcon A, and the like. A lens-forming material can further include other components, such as an initiator (e.g., a photoinitiator or a thermal initiator), a visibility tinting agent, UV-blocking agent, photosensitizers, and the like. Preferably, a silicone hydrogel lens-forming material used in the present invention comprises a silicone-containing macromer.

Examples of silicone-containing monomers include, without limitation, methacryloxyalkylsiloxanes, 3-methacryloxy propylpentamethyldisiloxane, bis(methacryloxypropyl)tetramethyl-disiloxane, monomethacrylated polydimethylsiloxane, mercapto-terminated polydimethylsiloxane, N-[tris(trimethylsiloxy)silylpropyl]acrylamide, N-[tris(trimethylsiloxy)silylpropyl]methacrylamide, tris(pentamethyldisiloxyanyl)-3-methacrylatopropylsilane (T2), and tristrimethylsilyloxysilylpropyl methacrylate (TRIS). A preferred siloxane-containing monomer is TRIS, which is referred to 3-methacryloxypropyltris(trimethylsiloxy) silane, and represented by CAS No. 17096-07-0. The term “TRIS” also includes dimers of 3-methacryloxypropyltris(trimethylsiloxy) silane.

Any suitable siloxane-containing macromer with ethylenically unsaturated group(s) can be used to produce a silicone hydrogel material. A particularly preferred siloxane-containing macromer is selected from the group consisting of Macromer A, Macromer B, Macromer C, and Macromer D described in U.S. Pat. No. 5,760,100, herein incorporated by reference in its entirety. Macromers that contain two or more polymerizable groups (vinylic groups) can also serve as cross linkers. Di and triblock macromers consisting of polydimethylsiloxane and polyakyleneoxides could also be of utility. Such macromers could be mono or difunctionalized with acrylate, methacrylate or vinyl groups. For example one might use methacrylate end capped polyethyleneoxide-block-polydimethylsiloxane-block-polyethyleneoxide to enhance oxygen permeability.

Examples of silicone-containing prepolymers include without limitation those disclosed in US Patent Application Publication No. US 2001-0037001 A1 and U.S. Pat. No. 6,039,913, which are incorporated herein by references in their entireties. Preferably, the prepolymers used in the invention are previously purified in a manner known per se, for example by precipitation with organic solvents, such as acetone, filtration and washing, extraction in a suitable solvent, dialysis or ultrafiltration, ultrafiltration being especially preferred. By means of that purification process the prepolymers can be obtained in extremely pure form, for example in the form of concentrated aqueous solutions that are free, or at least substantially free, from reaction products, such as salts, and from starting materials, such as, for example, non-polymeric constituents. The preferred purification process for the prepolymers used in the process according to the invention, ultrafiltration, can be carried out in a manner known per se. It is possible for the ultrafiltration to be carried out repeatedly, for example from two to ten times. Alternatively, the ultrafiltration can be carried out continuously until the selected degree of purity is attained. The selected degree of purity can in principle be as high as desired. A suitable measure for the degree of purity is, for example, the concentration of dissolved salts obtained as by-products, which can be determined simply in known manner.

In accordance with the present invention, a silicone hydrogel lens-forming material can also comprise a hydrophilic vinylic monomer. Nearly any hydrophilic vinylic monomer that can act as a plasticizer can be used in the fluid composition of the invention. Among the preferred hydrophilic monomers are N,N-dimethylacrylamide (DMA), 2-hydroxyethylmethacrylate (HEMA), hydroxyethyl acrylate, hydroxypropyl acrylate, hydroxypropyl methacrylate (HPMA), trimethylammonium 2-hydroxy propylmethacrylate hydrochloride, dimethylaminoethyl methacrylate (DMAEMA), dimethylaminoethylmethacrylamide, acrylamide, methacrylamide, allyl alcohol, vinylpyridine, glycerol methacrylate, N-(1,1dimethyl-3-oxobutyl)acrylamide, N-vinyl-2-pyrrolidone (NVP), acrylic acid, methacrylic acid, and N,N-dimethyacrylamide (DMA).

A silicone hydrogel lens-forming material can also comprises a hydrophobic monomer. By incorporating a certain amount of hydrophobic vinylic monomer in a polymerizable fluid composition, the mechanical properties (e.g., modulus of elasticity) of the resultant polymer may be improved.

A silicone hydrogel lens-forming material can further comprise an antimicrobial agent, preferably antimicrobial metal nanoparticles, more preferably silver nanoparticles.

In accordance with the present invention, a silicone hydrogel lens-forming material can further comprise various components, such as cross-linking agents, a chain transfer agent, initiator, UV-absorbers, inhibitors, fillers, visibility tinting agents (e.g., dyes, pigments, or mixtures thereof), and the like, as known to a person skilled in the art.

In accordance with the present invention, a silicone hydrogel lens-forming material can be a solution or a solvent-free liquid or melt at a temperature below 90° C. A person skilled in the art will known well how to prepare silicone hydrogel lens-forming material.

In accordance with the present invention, a silicone hydrogel lens-forming material can be a solution or a solvent-free liquid or melt at a temperature below 60° C.

Any non-crosslinkable hydrophilic polymers can be used in the invention. Exemplary non-crosslinkable hydrophilic polymers include, but are not limited to, polyvinylalcohols (PVAs), polyethylene oxide, polyethylene-polypropylene block copolymers, polyamides, polyimides, polylactone, a homopolymer of a vinyl lactam of formula (I) shown above, a copolymer of at least one vinyl lactam of formula (I) shown above in the presence or in the absence of one or more hydrophilic vinylic comonomers, a homopolymer of acrylamide or methaacrylamide, a copolymer of acrylamide or methacrylamide with one or more hydrophilic vinylic monomers, mixtures thereof.

A non-crosslinkable hydrophilic polymer is present in the silicone hydrogel lens-forming material in an amount sufficient to render a formed silicone hydrogel lens having a wettable and durable coating, for example, in an amount of from about 0.5% to about 10% by weight, preferably from about 1% to about 8.0% by weight, and more preferably from about 3% to about 6% by weight, each based on the entire weight of the composition.

The number-average molecular weight Mn of a non-crosslinkable hydrophilic polymer is at least 40000 daltons, preferably at least 80000 daltons, more preferably at least 100000 daltons, even more preferably at least 250000 daltons.

Examples of hydrophilic polymers include but are not limited to polyvinylalcohol (PVA), polyethylene oxide (i.e., polyethyleneglycol (PEG)), poly-N-vinyl pyrrolidone, poly-N-vinyl-2-piperidone, poly-N-vinyl-2-caprolactam, poly-N-vinyl-3-methyl-2-caprolactam, poly-N-vinyl-3-methyl-2-piperidone, poly-N-vinyl-4-methyl-2-piperidone, poly-N-vinyl-4-methyl-2-caprolactam, poly-N-vinyl-3-ethyl-2-pyrrolidone, and poly-N-vinyl4,5-dimethyl-2-pyrrolidone, polyvinylimidazole, poly-N—N-dimethylacrylamide, polyacrylic acid, poly 2 ethyl oxazoline, heparin polysaccharides, polysaccharides, a polyoxyethylene derivative, mixtures thereof.

A suitable polyoxyethylene derivative is, for example, a n-alkylphenyl polyoxyethylene ether, n-alkyl polyoxy-ethylene ether (e.g., TRITON®), polyglycol ether surfactant (TERGITOL®), polyoxyethylenesorbitan (e.g., TWEEN®), polyoxyethylated glycol monoether (e.g., BRIJ®, polyoxylethylene 9 lauryl ether, polyoxylethylene 10 ether, polyoxylethylene 10 tridecyl ether), or a block copolymer of ethylene oxide and propylene oxide (e.g. poloxamers or poloxamines).

A class of preferred polyoxyethylene derivatives used in the present invention are polyethylene-polypropylene block copolymers, in particular poloxamers or poloxamines which are available, for example, under the tradename PLURONIC®, PLURONIC-R®, TETRONIC®), TETRONIC-R® or PLURADOT®.

Poloxamers are triblock copolymers with the structure PEO-PPO-PEO (where “PEO” is poly(ethylene oxide) and “PPO” is poly(propylene oxide). A considerable number of poloxamers is known, differing merely in the molecular weight and in the PEO/PPO ratio; Examples are poloxamer 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403 and 407. The poloxamers may be used in the process of the invention irrespective of their PEO/PPO ratio; for example, poloxamer 101 having a PEO/PPO weight ratio of about 10/90 and poloxamer 108 having a PEO/PPO weight ratio of about 80/20 both have been found to be valuable as non-crosslinkable polymer in the aqueous solution according to step a).

The order of polyoxyethylene and polyoxypropylene blocks can be reversed creating block copolymers with the structure PPO-PEO-PPO, which are known as PLURONIC-R® polymers.

Poloxamines are polymers with the structure (PEO-PPO)2-N—(CH2)2—N-(PPO-PEO)2 that are available with different molecular weights and PEO/PPO ratios. Again, the order of polyoxyethylene and polyoxypropylene blocks can be reversed creating block copolymers with the structure (PPO-PEO)2-N—(CH2)2—N-(PEO-PPO)2, which are known as TETRONIC-R® polymers.

Polyoxypropylene-polyoxyethylene block copolymers can also be designed with hydrophilic blocks comprising a random mix of ethylene oxide and propylene oxide repeating units. To maintain the hydrophilic character of the block, ethylene oxide will predominate. Similarly, the hydrophobic block can be a mixture of ethylene oxide and propylene oxide repeating units. Such block copolymers are available under the tradename PLURADOT®.

PVA is a highly biocompatible material used widely in ophthalmic products, especially wetting drops or artificial tears for ocular comfort (e.g., HypoTears™, etc.). Non-crosslinkable PVAs of all kinds, for example those with low, medium or high polyvinyl acetate contents may be employed. The non-crosslinkable polyvinyl alcohols employed in the present invention are known and are commercially available, for example under the brand name Mowiol® from KSE (Kuraray Specialties Europe).

Preferably, a silicone-hydrogel lens-forming material comprises at least one high molecular weight non-crosslinkable PVA with a Mn of from above 50000 to 100000, preferably from above 50000 to 75000 and at least one low molecular weight non-crosslinkable PVA with a Mn of from 25000 to 50000, preferably from 30000 to 50000.

In case of two or more different non-crosslinkable PVAs, the total amount thereof in the composition is as described before including the preferences given. The weight proportion of the lower molecular weight and higher molecular weight non-crosslinkable PVA may vary within broad ranges, but is, for example, from 1:1 to 5:1, preferably from 1:1 to 4:1, and in particular from 1:1 to 3:1.

A mixture of non-crosslinkable PVAs and polyethyleneglycol (PEG) can be used in the invention. PVA and PEG may have synergy for enhancing surface wettability of a silicone hydrogel contact lens.

In accordance with the present invention, a silicone hydrogel lens-forming material can further comprise various components, such as cross-linking agents, initiator, UV-absorbers, inhibitors, fillers, visibility tinting agents (e.g., dyes, pigments, or mixtures thereof), and the like.

Cross-linking agents may be used to improve structural integrity and mechanical strength. Examples of cross-linking agents include without limitation allyl(meth)acrylate, lower alkylene glycol di(meth)acrylate, poly lower alkylene glycol di(meth)acrylate, lower alkylene di(meth)acrylate, divinyl ether, divinyl sulfone, di- or trivinylbenzene, trimethylolpropane tri(meth)acrylate, pentaerythritol tetra(meth)acrylate, bisphenol A di(meth)acrylate, methylenebis(meth)acrylamide, triallyl phthalate or diallyl phthalate. A preferred cross-linking agent is ethylene glycol dimethacrylate (EGDMA).

The amount of a cross-linking agent used is expressed in the weight content with respect to the total polymer and is preferably in the range from 0.05 to 5%, and more preferably in the range from 0.1 to 2%.

Initiators, for example, selected from materials well known for such use in the polymerization art, may be included in the polymerizable fluid composition in order to promote, and/or increase the rate of, the polymerization reaction. An initiator is a chemical agent capable of initiating polymerization reactions. The initiator can be a photoinitiator or a thermal initiator.

A photoinitiator can initiate free radical polymerization and/or crosslinking by the use of light. Suitable photoinitiators are benzoin methyl ether, diethoxyacetophenone, a benzoylphosphine oxide, 1-hydroxycyclohexyl phenyl ketone and Darocur and Irgacur types, preferably Darocur 1173® and Darocur 2959®. Examples of benzoylphosphine initiators include 2,4,6-trimethylbenzoyldiphenylophosphine oxide; bis-(2,6-dichlorobenzoyl)-4-N-propylphenylphosphine oxide; and bis-(2,6-dichlorobenzoyl)-4-N-butylphenylphosphine oxide. Reactive photoinitiators which can be incorporated, for example, into a macromer or can be used as a special monomer are also suitable. Examples of reactive photoinitiators are those disclosed in EP 632 329, herein incorporated by reference in its entirety. The polymerization can then be triggered off by actinic radiation, for example light, in particular UV light of a suitable wavelength. The spectral requirements can be controlled accordingly, if appropriate, by addition of suitable photosensitizers

Examples of suitable thermal initiators include, but are not limited to, 2,2′-azobis (2,4-dimethylpentanenitrile), 2,2′-azobis(2-methylpropanenitrile), 2,2′-azobis(2-methylbutanenitrile), peroxides such as benzoyl peroxide, and the like. Preferably, the thermal initiator is azobisisobutyronite (AIBN).

Examples of preferred pigments include any colorant permitted in medical devices and approved by the FDA, such as D&C Blue No. 6, D&C Green No. 6, D&C Violet No. 2, carbazole violet, certain copper complexes, certain chromium oxides, various iron oxides, phthalocyanine green, phthalocyanine blue, titanium dioxides, etc. See Marmiom D M Handbook of U.S. Colorants for a list of colorants that may be used with the present invention. A more preferred embodiment of a pigment include (C.I. is the color index no.), without limitation, for a blue color, phthalocyanine blue (pigment blue 15:3, C.I. 74160), cobalt blue (pigment blue 36, C.I. 77343), Toner cyan BG (Clariant), Permajet blue B2G (Clariant); for a green color, phthalocyanine green (Pigment green 7, C.I. 74260) and chromium sesquioxide; for yellow, red, brown and black colors, various iron oxides; PR122, PY154, for violet, carbazole violet; for black, Monolith black C-K (CIBA Specialty Chemicals).

In a preferred embodiment, a polymerizable fluid composition suitable for making an ophthalmic device will include (a) about 20 to 40 weight percent of a siloxane-containing macromer with ethylenically unsaturated groups, (b) about 5 to 30 weight percent of a siloxane-containing vinylic monomer, and (c) about 10 to 35 weight percent of a hydrophilic monomer. More preferably, the siloxane-containing vinylic monomer is TRIS.

In another preferred embodiment, where a lens-forming material is a solution (dissolved in water, a mixture of water and a water miscible organic solvent, or an organic solvent), solvent-free liquid, or melt of one or more silicone-containing prepolymers with ethylenically unsaturated groups optionally in presence of other components, reusable molds are used and the lens-forming material is cured actinically under a spatial limitation of actinic radiation to form a contact lens. Examples of silicone-containing prepolymers include without limitation those disclosed in US Patent Application Publication No. US 2001-0037001 A1 and U.S. Pat. No. 6,039,913, which are incorporated herein by references in their entireties. Examples of preferred reusable molds are those disclosed in U.S. Patent Application Publication No. US 2004-0178541 A1 and U.S. Pat. Nos. 6,627,124, 6,800,225, which are incorporated by reference in their entireties. In this preferred embodiment, preferably the lens-forming material is substantially free of vinylic monomers and the silicone-containing prepolymer is substantially purified prior to making the lens-forming material (formulation). As such, no extraction step is necessary after cast-molding step and the production cost can be reduced.

In this case, the lens-forming material is put into a mold consisting of two mold halves, the two mold halves not touching each other but having a thin gap of annular design arranged between them. The gap is connected to the mold cavity, so that excess lens material can flow away into the gap. Instead of polypropylene molds that can be used only once, it is possible for reusable quartz, glass, sapphire molds to be used, since, following the production of a lens, these molds can be cleaned rapidly and effectively off the uncrosslinked prepolymer and other residues, using water or a suitable solvent, and can be dried with air. Reusable molds can also be made of a cyclic olefin copolymer, such as for example, Topas® COC grade 8007-S10 (clear amorphous copolymer of ethylene and norbornene) from Ticona GmbH of Frankfurt, Germany and Summit, N.J., Zeonex® and Zeonor® from Zeon Chemicals LP, Louisville, Ky. Because of the reusability of the mold halves, a relatively high outlay can be expended at the time of their production in order to obtain molds of extremely high precision and reproducibility. Since the mold halves do not touch each other in the region of the lens to be produced, i.e. the cavity or actual mold faces, damage as a result of contact is ruled out. This ensures a high service life of the molds, which, in particular, also ensures high reproducibility of the contact lenses to be produced.

The two opposite surfaces (anterior surface and posterior surface) of a contact lens are defined by the two molding surfaces while the edge is defined by the spatial limitation of actinic irradiation rather than by means of mold walls. Typically, only the lens-forming material within a region bound by the two molding surfaces and the projection of the well defined peripheral boundary of the spatial limitation is crosslinked whereas any lens-forming material outside of and immediately around the peripheral boundary of the spatial limitation is not crosslinked, and thereby the edge of the contact lens should be smooth and precise duplication of the dimension and geometry of the spatial limitation of actinic radiation. Such method of making contact lenses are described in U.S. Patent Application Publication No. US 2004-0178541 A1 and U.S. Pat. Nos. 6,627,124, 6,800,225, which are incorporated by reference in their entireties.

A spatial limitation of actinic radiation (or the spatial restriction of energy impingement) can be effected by masking for a mold that is at least partially impermeable to the particular form of energy used, as illustrated in U.S. Pat. Nos. 6,627,124, 6,800,225 (herein incorporated by reference in their entireties) or by a mold that is highly permeable, at least at one side, to the energy form causing the crosslinking and that has mold parts being impermeable or of poor permeability to the energy, as illustrated in U.S. Patent Application Publication No. US 2004-0178541 A1 and U.S. Pat. Nos. 6,627,124, 6,800,225 (herein incorporated by reference in their entireties). The energy used for the crosslinking is radiation energy, especially UV radiation, gamma radiation, electron radiation or thermal radiation, the radiation energy preferably being in the form of a substantially parallel beam in order on the one hand to achieve good restriction and on the other hand efficient use of the energy.

In another preferred embodiment, a silicone hydrogel lens-forming material further comprises at least one antimicrobial agent, preferably silver nanoparticles in an amount sufficient to impart to the resultant silicone hydrogel material an antimicrobial activity characterized by having at least a 5-fold reduction (≧80% inhibition), preferably at least a 1-log reduction (≧90% inhibition), more preferably at least a 2-log reduction (≧99% inhibition), of viable microorganisms (e.g., Pseudomonas aeruginosa GSU # 3, or Staphylococcus aureus ATCC #6538), preferably by having a prolong antimicrobial activity (i.e., effective antimicrobial activity after direct contact with a body fluid over an extended period of time). Antimicrobial activity can be determined according to procedure described in the Examples of U.S. Patent Application Publication No. US 2005-0013842 A1 (herein incorporated by reference in its entirety).

As used herein, a “prolong antimicrobial activity” is characterized by having at least a 5-fold reduction (≧80% inhibition), preferably at least a 1-log reduction (≧90% inhibition), more preferably at least a 2-log reduction (≧99% inhibition), of viable microorganisms (e.g., Pseudomonas aeruginosa GSU # 3, or Staphylococcus aureus ATCC #6538) after at least 5, preferably at least 10, more preferably at least 20, even more preferably at least 30 consecutive soaking/rinsing cycles, each cycle comprising soaking/rinsing one lens in a phosphate buffered saline (PBS) for a period of time from about 24 to about 72 hours, as shown in the Examples of U.S. Patent Application Publication No. US 2005-0013842 A1 (herein incorporated by reference in its entirety).

In accordance with the invention, the soaking time is preferably shorter than about 20 minutes, more preferably shorter than about 10 minutes, even more preferably shorter than about 5 minutes.

In a preferred embodiment, the lens-forming fluid material has a temperature of from about 45° C. to about 95° C. At such a relative high temperature, the soaking of the transferable LbL coatings with the lens-forming fluid material can be accelerated. Moreover, it is believed that at a relatively high temperature, the structure of the non-crosslinkable hydrophilic polymer may not be tightly compact (or aggregated) but may likely be extended (i.e., with the chains extending out) so that portions of the non-crosslinkable hydrophilic polymer in the interfacial film can extend into the polymer matrix of a formed lens, thereby increasing the durability of the coatings on the formed contact lenses.

A resultant contact lens has a wettable and durable coating characterized by surviving at least 5 consecutive digital rubbing tests.

A resultant contact lens has an oxygen permeability of at least 40 barres, preferably at least about 50 barrers, more preferably at least about 65 barrers, even more preferably at least about 80 barrers. In accordance with the invention, an oxygen permeability is an apparent (directly measured when testing a sample with a thickness of about 100 microns) oxygen permeability according to procedures described in Examples.

A resultant contact lens can further have a elastic modulus of about 1.5 MPa or less, preferably about 1.2 MPa or less, more preferably about 1.0 or less, even more preferably from about 0.4 MPa to about 1.0 MPa.

A resultant contact lens further has an Ionoflux Diffusion Coefficient, D, of, preferably at least about 1.5×10−6 mm2/min, more preferably at least about 2.6×10−6 mm2/min, even more preferably at least about 6.4×10−6 mm2/min.

A resultant contact lens further has a water content of preferably from about 18% to about 55%, more preferably from about 20% to about 38% by weight when fully hydrated. The water content of a silicone hydrogel contact lens can be measured according to Bulk Technique as disclosed in U.S. Pat. No. 5,849,811.

In another aspect, the invention provide a method for making for making a silicone hydrogel contact lens, comprising the steps of: (a) cast-molding a silicone hydrogel contact lens from a silicone hydrogel lens-forming material, wherein the silicone-hydrogel lens-forming material comprises a non-crosslinkable hydrophilic polymer with a hydrophobic backbone and at least one member selected from the group consisting of a silicone-containing vinylic monomer, a silicone-containing macromer with ethylenically unsaturated groups, a crosslinkable silicone-containing prepolymer, and mixtures thereof; (b) applying a LbL coating onto the resultant silicone hydrogel contact lens at a temperature from about 45° C. to about 95° C., wherein the LbL coating comprises at least one layer of a first polyionic polymeric material and optionally at least one layer of a second polyionic material or a non-charged hydrophilic polymer with a hydrophobic backbone, wherein the first and second polyionic material each have a hydrophobic backbone and multiple ionizable or charged pendant groups, wherein the non-crosslinkable hydrophilic polymer has a molecular weight or structure that promotes entanglement of the non-crosslinkable hydrophilic polymer in the interfacial film with the polymer matrix of the formed lens so as to obtain a wettable surface coating with a good coating durability characterized by surviving at least five consecutive digital rubbing tests.

Although the inventors do not wish to be bound by any particular theory, it is believed that where a non-crosslinkable hydrophilic polymer is incorporated in a silicone hydrogel lens-forming fluid material for cast-molding of lenses, an interfacial film composed of non-crosslinkable hydrophilic polymer can be formed at the interface between the lens-forming material and the molding surface of a mold prior to polymerization (curing). Such interfacial film of non-crosslinkable hydrophilic polymer can become the integral part of the resultant lens if the non-crosslinkable hydrophilic polymer has a high molecular weight or a structure to ensure that portions (e.g., relatively long tails or dangling polymer chain segments) of the non-crosslinkable molecules are entrapped within and become entangled with the polymer matrix of a formed lens. Such interfacial film (or coating) on the lens may not be intact and/or durable. But, by applying an LbL coating on top of this interfacial film at a relatively high temperature (e.g., a temperature of from about 45° C. to about 95° C.), one can obtain a new coating with greatly improved intactness and durability. It is also believed that at a relatively high temperature, the structure of the non-crosslinkable hydrophilic polymer in the interfacial film tends to be extended so as to facilitate the hydrophobic-hydrophobic interactions between the hydrophobic backbones of LbL coating materials and the non-crosslinkable hydrophilic polymer. As such, the LbL coating materials intertwine with non-crosslinkable hydrophilic material to form a new coating on the lens surface to provide improved intactness and durability.

In accordance with the invention, the phrase “applying an LbL coating onto the resultant silicone hydrogel contact lens at a temperature of from about 45° C. to about 95° C.” is intended to describe that the LbL coating is formed by contacting the lens with one or more LbL coating solutions having a temperature of from about 45° C. to about 95° C. The temperature of a coating solution is preferably above 50° C., more preferably above about 60° C., even more preferably above about 70° C., most preferably at about 80° C. or above.

In a preferred embodiment, the cast-molding step is carried out at a temperature of from about 45° C. to about 95° C. Cast-molding at a relatively high temperature can ensure that an interfacial film of the non-crosslinkable hydrophilic polymer is formed in a shorter time period at the interface between a silicone-hydrogel lens-forming material and a mold and that greater portions of the non-crosslinkable hydrophilic polymer in the interfacial film can extend into the polymer matrix of a formed lens.

In a further aspect, the invention provides a silicone hydrogel contact lens made according to a method of the invention described above.

The previous disclosure will enable one having ordinary skill in the art to practice the invention. In order to better enable the reader to understand specific embodiments and the advantages thereof, reference to the following examples is suggested.

Example 1 Synthesis of Macromer

51.5 g (50 mmol) of the perfluoropolyether Fomblin® ZDOL (from Ausimont S.p.A, Milan) having a mean molecular weight of 1030 g/mol and containing 1.96 meq/g of hydroxyl groups according to end-group titration is introduced into a three-neck flask together with 50 mg of dibutyltin dilaurate. The flask contents are evacuated to about 20 mbar with stirring and subsequently decompressed with argon. This operation is repeated twice. 22.2 g (0.1 mol) of freshly distilled isophorone diisocyanate kept under argon are subsequently added in a counterstream of argon. The temperature in the flask is kept below 30° C. by cooling with a waterbath. After stirring overnight at room temperature, the reaction is complete. Isocyanate titration gives an NCO content of 1.40 meq/g (theory: 1.35 meq/g).

202 g of the α,ω-hydroxypropyl-terminated polydimethylsiloxane KF-6001 from Shin-Etsu having a mean molecular weight of 2000 g/mol (1.00 meq/g of hydroxyl groups according to titration) are introduced into a flask. The flask contents are evacuated to approx. 0.1 mbar and decompressed with argon. This operation is repeated twice. The degassed siloxane is dissolved in 202 ml of freshly distilled toluene kept under argon, and 100 mg of dibutyltin dilaurate (DBTDL) are added. After complete homogenization of the solution, all the perfluoropolyether reacted with isophorone diisocyanate (IPDI) is added under argon. After stirring overnight at room temperature, the reaction is complete. The solvent is stripped off under a high vacuum at room temperature. Microtitration shows 0.36 meq/g of hydroxyl groups (theory 0.37 meq/g).

13.78 g (88.9 mmol) of 2-isocyanatoethyl methacrylate (IEM) are added under argon to 247 g of the α,σ-hydroxypropyl-terminated polysiloxane-perfluoropolyether-polysiloxane three-block copolymer (a three-block copolymer on stoichiometric average, but other block lengths are also present). The mixture is stirred at room temperature for three days. Microtitration then no longer shows any isocyanate groups (detection limit 0.01 meq/g). 0.34 meq/g of methacryl groups is found (theory 0.34 meq/g).

The macromer prepared in this way is completely colorless and clear. It can be stored in air at room temperature for several months in the absence of light without any change in molecular weight.

Example 2

Lens formulation A1 comprises the following components: about 40.9% by weight of macromer prepared in Example 1, about 16.4% by weight of TRIS, about 24.6% by weight of DMA, about 17.6% by weight of ethanol, and about 0.5% by weight of Darocure® 1173.

Lens formulation A2 is prepared by adding about 1% by weight of polyvinylpyrrolidone (PVP K90) in the A1 lens formulation.

Lens Formulation A3 is prepared by adding about 5% by weight of PVP K90 in the A1 lens formulation.

Lens Formulation A4 is prepared by adding about 8% by weight of PVP K90 in the A1 lens formulation.

Example 3 Preparation of Polyacrylic Acid (PAA) Solutions

A solution of polyacrylic acid is prepared by adding 1.154 grams (25% PAA solution, 90K, Mw: 72.07 from Polyscience, Inc.) into 4000 ml of water. This solution is divided into 3 parts: B1 (337 ml); B2 (3300 ml); and B3 (363 ml). The pH of B1 is adjusted to pH=6.0; the pH of B2 is adjusted to pH=2.0; the pH of B3 is adjusted to pH=2.0.

Preparation of Poly(allylamine hydrochloride) (PAH) solutions: A solution of PAH of polyacrylic acid is prepared by adding 0.346 grams PAH (Aldrich Mw˜70 k) in 3700 ml of water. This solution is divided into 2 parts: C1 (330 ml) and C2 (3370 ml). The pH of C1 is adjusted to pH=2.0; the pH of C2 is adjusted to pH=6.0.
Preparation of PAA/PAH solution: A solution of PAA/PAH is prepared by slowly adding 330 ml of C1 (PAH, pH=2.0) into 3300 ml of B2 (PAA, pH=2.0). Mix thoroughly the resultant solution and then filter the solution.
Preparation of PAH/PAA solution: A solution of PAH/PAA is prepared by slowly adding 337 ml of B1 (PAA, pH=6.0) into 3370 ml of C2 (PAH, pH=6.0). Mix thoroughly the resultant solution and then filter the solution.

Example 4

This example teaches the coating procedures used in the experiments.

Presoak the mold halves (or lenses) for 15 minutes in B3 (PAA solution, pH=2.0) prepared in Example 3, prior to placing them in a tray (i.e., pre-conditioning step). Load the preconditioned mold halves (or lenses) into the carrier trays and agitate for 5 minutes in each solution bath in the following sequence: Bath # 1 PA/PAH (pH=2.0); Bath # 2 PAH/PAA (pH=6.0); Bath # 2 PA/PAH (pH=2.0); Bath # 4 PAH/PAA (pH=6.0); Bath # 5 PAA/PAH (pH=2.0); Bath # 6 PAH/PAA (pH=6.0); Bath # 7 PA/PAH (pH=2.0); Bath # 8 PAH/PAA (pH=6.0); and Bath # 9 PA/PAH (pH=2.0). Transfer mold halves (or lenses) into a saline.

Example 5 Surface Hydrophilicity (Wettability) Tests

Water contact angle on a contact lens is a general measure of the surface hydrophilicity (or wettability) of the contact lens. In particular, a low water contact angle corresponds to more hydrophilic surface. Contact angles (water), both advancing and receding contact angles, of contact lenses are measured by Wilhelmy Plate. The measurements are performed on fully hydrated contact lenses and immediately after blot-drying. Average contact angles are obtained by averaging measurements of three contact lenses.

Coating Intactness Tests

The intactness of a coating on the surface of a contact lens can be tested according to Sudan Black stain test as follows. Contact lenses with a coating (an LbL coating, a plasma coating, or any other coatings) are dipped into a Sudan Black dye solution (Sudan Black in vitamin E oil). Sudan Black dye is hydrophobic and has a great tendency to be adsorbed by a hydrophobic material or onto a hydrophobic lens surface or hydrophobic spots on a partially coated surface of a hydrophobic lens (e.g., silicone hydrogel contact lens). If the coating on a hydrophobic lens is intact, no staining spots should be observed on or in the lens. All of the lenses under test are fully hydrated.

Coating Durability Tests

The lenses are digitally rubbed 30 times with Aquify® multi-purpose lens care solution and then rinsed with Softwear®) saline. The digitally rubbed lenses are then soaked in Softwear® saline for 30 minutes and the procedure repeated until 30 digital rubbing and soaking cycles had been completed. The lenses are then subjected to Sudan Black test (i.e., coating intactness test described above) to examine whether the coating is still intact.

Example 6

Experiments are carried out to determine the surface hydrophilicity of contact lenses prepared using lens mold halves with an LbL coating and without LbL coating. The results are shown in Table I.

TABLE 1
Coating Coating
Exp. Lens of mold Temperature Contact Angles (degrees)
No. Formulation halves (° C.) Advancing Receding
1 A1 Yes Room 106 ± 3  49 ± 3
temperature
2 A1 No N/A 108 ± 7  54 ± 4
3 A2 No N/A 108 ± 7  54 ± 4
4 A3 No N/A 85 ± 9 55 ± 8
5 A4 No N/A 103 ± 3  51 ± 4
6 A2 Yes Room 72 ± 4  40 ± 11
temperature
7 A2 Yes 80 70 ± 9 45 ± 8
8 A3 Yes Room 46 ± 9 40 ± 7
temperature
9 A3 Yes 80 51 ± 6 48 ± 8
10  A1 No Room 29 ± 5 21 ± 3
temperature
11  A1 No 80 20 ± 6  9 ± 9
12* A4 Yes Room 90 ± 4 43 ± 9
temperature
13* A4 Yes 80 82 ± 8 41 ± 4
14  A1 Yes Room 116 ± 14 53 ± 8
temperature
*At this PVP concentration, PVP did not mix thoroughly with the lens formulation and formed a separate phase.

Polypropylene molds have been used for making lenses. An amount of a lens formulation is introduced into each polypropylene molds and cured for a desired period of time, e.g., from about 15 to about 30 minutes, under UV light to form contact lenses.

Mold halves in experiments 1, 6-9, and 12-13 are coated according to the coating procedure described in Example 4 at a temperature indicated in Table I (coating solution temperature). The resultant mold halves have theoretically 9½ bilayers (PA/(PAH/PAA)9. Those mold halves are then used to cast mold lenses using a lens formulation indicated in Table 1.

Mold halves in experiment 14 are coated by spraying coating using a spray mister as follows. Molds halve are placed on a tray, misted with the 1% PVP k90 solution, and then placed into an oven set at 45° to dry. Once the mold halves are dry, they are removed from the oven and an additional misting is applied on them. This procedure is repeated until a total of 10 b-layers of the PVP k90 had been applied. Mold halves are used for the casting of lenses from lens formulation A1 prepared in Example 2. Mold-lens assemblies (molded lenses with mold halves) are released in a PAA solution (pH 2.0), then extracted for 4 hrs in the PAA solution.

Lenses in experiment 10 and 11 are obtained by cast-molding of lens formulation A1 in mold halves without LbL coating. The molded lenses are coated with an LbL coating according to the procedure described in Example 4. The resultant lenses have theoretically 9½ bilayers (PAA/(PAH/PAA)9.

The results in Table I shows that by using a method of invention (i.e., combination of a transferable LbL coating on mold halves and incorporation of internal wetting agent in a lens formulation), see experiments 6-9, contact lenses with wettable coatings can be produced in a simple, cost effective manner.

It is found that the contact-angle hysteresis can be lowered by combination of a transferable LbL coating on mold halves for making lenses and incorporation of appropriate amounts of internal wetting agent in a lens formulation (experiments 8-9). Contact-angle hysteresis is the difference between the advancing and receding contact angles. Contact angle hysteresis can be used to characterize surface heterogeneity. Where the surface of a contact lens is not chemically homogeneous, there will exist domains with different hydrophilicity or hydrophobicity on the surface. Generally, advancing angles will be sensitive to the hydrophobic domains and receding angles will characterize the hydrophilic domains on the surface, because as the water advances hydrophobic domains will hinder the advancing motion of the contact line, thereby increasing the contact angles, while as the water recedes, the hydrophilic domains will hold back the draining motion of the contact line thus decreasing the contact angle.

It is also found that the higher temperature coating temperature may increase the surface of hydrophilicity of the coating on a contact lens.

Example 7

A. An amount of lens formulation A1 (containing no PVP) prepared in Example 2 is introduced into each polypropylene molds and cured for a desired period of time, e.g., from about 15 to about 30 minutes, under UV light to form contact lenses. The lens molds are not coated with LbL coating. After molding, Mold-lens assemblies (molded lenses with mold halves) are released in a PAA solution (pH 2.0), then extracted for 4 hrs in the PAA solution. After extraction, lenses are autoclaved in phosphate buffer saline (PBS). The averaged contact angle are determined by Wilhelmy plate. The averaged advancing contact angle is 78±5 degrees and the averaged receding contact angle is 30±4 degrees.
B. An amount of lens formulation A2 (containing 1% by weight of PVP) prepared in Example 2 is introduced into each polypropylene molds and cured for a desired period of time, e.g., from about 15 to about 30 minutes, under UV light to form contact lenses. The lens molds are coated with an LbL coating according to the procedure described in Example 4. After molding, Mold-lens assemblies (molded lenses with mold halves) are released in a PAA solution (pH 2.0), then extracted for 4 hrs in the PAA solution. After extraction, lenses are autoclaved in phosphate buffer saline (PBS). The averaged contact angle are determined by Wilhelmy plate. The averaged advancing contact angle is 86.3±9.7 degrees and the averaged receding contact angle is 28.1±8.8 degrees.
C. An amount of lens formulation A3 (containing 5% by weight of PVP) prepared in Example 2 is introduced into each polypropylene molds and cured for a desired period of time, e.g., from about 15 to about 30 minutes, under UV light to form contact lenses. The lens molds are coated with an LbL coating according to the procedure described in Example 4. After molding, Mold-lens assemblies (molded lenses with mold halves) are released in a PAA solution (pH 2.0), then extracted for 4 hrs in the PAA solution. After extraction, lenses are autoclaved in phosphate buffer saline (PBS). The averaged contact angle are determined by Wilhelmy plate. The averaged advancing contact angle is 88.4±3.3 degrees and the averaged receding contact angle is 19.8±8.3 degrees.
D. An amount of lens formulation A1 (containing no PVP) prepared in Example 2 is introduced into each polypropylene molds and cured for a desired period of time, e.g., from about 15 to about 30 minutes, under UV light to form contact lenses. The lens molds are spray-coated with 10 bi-layers of the PVP k90 according to the procedure described in Example 6. After molding, Mold-lens assemblies (molded lenses with mold halves) are released in a PAA solution (pH 2.0), then extracted for 4 hrs in the PAA solution. After extraction, lenses are autoclaved in phosphate buffer saline (PBS).

All lenses prepared above are subjected to coating durability test as described in Example 5. It is observed that after 30 digital rubbing and soaking cycles, all of the tested lenses have staining spots, but the extent of Sudan Black staining for the above prepared lenses B, C and D is smaller than that for lenses A.

Although various embodiments of the invention have been described using specific terms, devices, and methods, such description is for illustrative purposes only. The words used are words of description rather than of limitation. It is to be understood that changes and variations may be made by those skilled in the art without departing from the spirit or scope of the present invention, which is set forth in the following claims. In addition, it should be understood that aspects of the various embodiments may be interchanged either in whole or in part. Therefore, the spirit and scope of the appended claims should not be limited to the description of the preferred versions contained therein.

Claims (20)

1. A method for making a silicone hydrogel contact lens, comprising the steps of:
(a) obtaining a mold having a first mold half and a second mold half, wherein the first mold half includes a first molding surface and the second mold half includes a second molding surface, wherein the first and second mold halves are configured to receive each other such that a lens-forming cavity is formed between the first molding surface and the second molding surface;
(b) applying a first transferable LbL coating to the first molding surface and a second transferable LbL coating to the second molding surface, wherein each of the first and second transferable LbL coatings comprises at least one layer of a first polyionic polymeric material and optionally at least one layer of a second polyionic material or a non-charged hydrophilic polymer with a hydrophobic backbone, wherein the first and second polyionic material each have a hydrophobic backbone and multiple ionizable or charged pendant groups, wherein the first and second polyionic materials have charges opposite to each other;
(c) dispensing a silicone hydrogel lens-forming fluid material into the lens-forming cavity of the mold with the first and second transferable LbL coatings on their molding surfaces, wherein the silicone-hydrogel lens-forming material comprises a non-crosslinkable hydrophilic polymer and at least one member selected from the group consisting of a silicone-containing vinylic monomer, a silicone-containing macromer with ethylenically unsaturated groups, a crosslinkable silicone-containing prepolymer, and mixtures thereof, wherein the non-crosslinkable hydrophilic polymer is capable of forming an interfacial film at an interface between the coated molding surfaces and the lens-forming fluid material;
(d) soaking the transferable LbL coatings with the lens-forming fluid material for a time period sufficient both to allow the non-crosslinkable hydrophilic polymer in the interface film to penetrate into the transferable LbL coatings and to entangle with coating materials in the transferable LbL coatings; and
(e) curing the lens-forming material within the lens-forming cavity to form the silicone hydrogel contact lens, whereby the transferable LbL coatings detach from the molding surfaces and reattach to the formed silicone hydrogel contact lens such that said silicone hydrogel contact lens becomes coated with the transferable LbL coatings,
wherein the non-crosslinkable hydrophilic polymer has a molecular weight or structure that promotes entanglement of the non-crosslinkable hydrophilic polymer in the interfacial film with the polymer matrix of the formed lens so as to obtain a wettable surface coating with a good coating durability characterized by surviving at least five consecutive digital rubbing tests.
2. The method of claim 1, wherein the silicone hydrogel lens-forming fluid material has a temperature of from about 45° C. to about 95° C.
3. The method of claim 2, wherein each of the first and second transferable LbL coatings comprises at least one layer of the first polyionic polymeric material and at least one layer of the second polyionic material.
4. The method of claim 2, wherein each of the first and second transferable LbL coatings comprises at least one layer of the first polyionic polymeric material and at least one layer of the non-charged hydrophilic polymer with a hydrophobic backbone, wherein the non-charged hydrophilic polymer is selected from the group consisting of a polyvinyl alcohol, a homopolymer of a vinyl lactam, a copolymer of at least one vinyl lactam with one or more hydrophilic vinylic comonomers, and mixtures thereof.
5. The method of claim 4, wherein the non-charged hydrophilic polymer is a polyvinyl alcohol, polyvinylpyrrolidone, or a mixture thereof.
6. The method of claim 2, wherein the first and second transferable LbL coatings are different from each other.
7. The method of claim 2, wherein the silicone hydrogel lens-forming fluid material comprises from about 1% to about 8.0% by weight of the non-crosslinkable hydrophilic polymer, wherein the non-crosslinkable hydrophilic polymer is selected from the group consisting of a polyvinylalcohol, polyethylene oxide, a polyethylene-polypropylene block copolymers, polyamides, a polyimides, a polylactone, a homopolymer of a vinyl lactam, a copolymer of a vinyl lactam, a homopolymer of acrylamide, a homopolymer of methaacrylamide, a copolymer of acrylamide, a copolymer of methacrylamide with one or more hydrophilic vinylic monomers, and mixtures thereof, wherein the number-average molecular weight Mn of a non-crosslinkable hydrophilic polymer is at least 40000 daltons.
8. The method of claim 2, wherein the silicone hydrogel lens-forming material further comprises silver nanoparticles in an amount sufficient to impart to the resultant silicone hydrogel contact lens an antimicrobial activity characterized by having at least a 5-fold reduction (≧80% inhibition).
9. The method of claim 1, wherein the silicone hydrogel lens-forming material comprises a crosslinkable silicone-containing prepolymer and is substantially free of vinylic monomer, wherein the crosslinkable silicone-containing prepolymer is substantially purified prior to preparation of the silicone-hydrogel lens-forming fluid material, wherein the step of curing is carried out under a spatial limitation of actinic radiation to form the contact lens.
10. The method of claim 1, wherein each of the first and second transferable LbL coatings comprises at least one layer of the first polyionic polymeric material and at least one layer of the second polyionic material.
11. The method of claim 1, wherein each of the first and second transferable LbL coatings comprises at least one layer of the first polyionic polymeric material and at least one layer of the non-charged hydrophilic polymer with a hydrophobic backbone, wherein the non-charged hydrophilic polymer is selected from the group consisting of a polyvinyl alcohol, a homopolymer of a vinyl lactam, a copolymer of at least one vinyl lactam with one or more hydrophilic vinylic comonomers, and mixtures thereof.
12. The method of claim 11, wherein the non-charged hydrophilic polymer is a polyvinyl alcohol, polyvinylpyrrolidone, or a mixture thereof.
13. The method of claim 1, wherein the first and second transferable LbL coatings are different from each other.
14. The method of claim 1, wherein the silicone hydrogel lens-forming fluid material comprises from about 1% to about 8.0% by weight of the non-crosslinkable hydrophilic polymer, wherein the non-crosslinkable hydrophilic polymer is selected from the group consisting of a polyvinylalcohol, polyethylene oxide, a polyethylene-polypropylene block copolymers, polyamides, a polyimides, a polylactone, a homopolymer of a vinyl lactam, a copolymer of a vinyl lactam, a homopolymer of acrylamide, a homopolymer of methaacrylamide, a copolymer of acrylamide, a copolymer of methacrylamide with one or more hydrophilic vinylic monomers, and mixtures thereof, wherein the number-average molecular weight Mn of a non-crosslinkable hydrophilic polymer is at least 40000 daltons.
15. The method of claim 1, wherein the silicone hydrogel lens-forming material further comprises silver nanoparticles in an amount sufficient to impart to the resultant silicone hydrogel contact lens an antimicrobial activity characterized by having at least a 5-fold reduction (≧80% inhibition).
16. The method of claim 9, wherein the silicone hydrogel lens-forming fluid material has a temperature of from about 45° C. to about 95° C.
17. The method of claim 16, wherein each of the first and second transferable LbL coatings comprises at least one layer of the first polyionic polymeric material and at least one layer of the second polyionic material.
18. The method of claim 16, wherein each of the first and second transferable LbL coatings comprises at least one layer of the first polyionic polymeric material and at least one layer of the non-charged hydrophilic polymer with a hydrophobic backbone, wherein the non-charged hydrophilic polymer is selected from the group consisting of a polyvinyl alcohol, a homopolymer of a vinyl lactam, a copolymer of at least one vinyl lactam with one or more hydrophilic vinylic comonomers, and mixtures thereof.
19. The method of claim 18, wherein the non-charged hydrophilic polymer is a polyvinyl alcohol, polyvinylpyrrolidone, or a mixture thereof.
20. The method of claim 16, wherein the first and second transferable LbL coatings are different from each other.
US11810601 2006-06-08 2007-06-06 Method of making silicone hydrogel contact lenses Active 2029-10-08 US7858000B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US81194906 true 2006-06-08 2006-06-08
US11810601 US7858000B2 (en) 2006-06-08 2007-06-06 Method of making silicone hydrogel contact lenses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11810601 US7858000B2 (en) 2006-06-08 2007-06-06 Method of making silicone hydrogel contact lenses

Publications (2)

Publication Number Publication Date
US20080174035A1 true US20080174035A1 (en) 2008-07-24
US7858000B2 true US7858000B2 (en) 2010-12-28

Family

ID=38720078

Family Applications (1)

Application Number Title Priority Date Filing Date
US11810601 Active 2029-10-08 US7858000B2 (en) 2006-06-08 2007-06-06 Method of making silicone hydrogel contact lenses

Country Status (6)

Country Link
US (1) US7858000B2 (en)
EP (1) EP2029349B1 (en)
JP (1) JP5064498B2 (en)
CA (1) CA2644791C (en)
DE (1) DE602007008891D1 (en)
WO (1) WO2007146137A3 (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100135935A1 (en) * 2008-11-28 2010-06-03 Leshchiner Adelya K Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
US20110076243A1 (en) * 2009-09-28 2011-03-31 Leshchiner Adelya K Modified hydrophilic polymers containing hydrophobic groups
US20110133350A1 (en) * 2009-12-07 2011-06-09 Yongxing Qiu Methods for increasing the ion permeability of contact lenses
US20110140292A1 (en) * 2009-12-14 2011-06-16 Frank Chang Methods for making silicone hydrogel lenses from water-based lens formulations
US8357771B2 (en) 2006-12-13 2013-01-22 Novartis Ag Production of ophthalmic devices based on photo-induced step growth polymerization
US20130341811A1 (en) * 2012-06-25 2013-12-26 Johnson & Johnson Vision Care, Inc. Lens comprising low and high molecular weight polyamides
US20150115485A1 (en) * 2013-10-31 2015-04-30 Novartis Ag Method for producing ophthalmic lenses
US9096025B2 (en) 2008-07-21 2015-08-04 Novartis Ag Silicone hydrogel lenses with convertible comfort agents
WO2016048853A1 (en) 2014-09-26 2016-03-31 Novartis Ag Polymerizable polysiloxanes with hydrophilic substituents
US9310627B2 (en) 2013-11-15 2016-04-12 Ocular Dynamics, Llc Contact lens with a hydrophilic layer
US9315669B2 (en) 2013-09-30 2016-04-19 Novartis Ag Method for making UV-absorbing ophthalmic lenses
US9395468B2 (en) 2012-08-27 2016-07-19 Ocular Dynamics, Llc Contact lens with a hydrophilic layer
US9568645B2 (en) 2013-09-30 2017-02-14 Novartis Ag Silicone hydrogel lenses with relatively-long thermal stability
WO2017093834A1 (en) 2015-12-03 2017-06-08 Novartis Ag Contact lens packaging solutions
US9684095B2 (en) 2014-04-25 2017-06-20 Novartis Ag Hydrophilized carbosiloxane vinylic monomers
WO2017103790A1 (en) 2015-12-15 2017-06-22 Novartis Ag Hydrophilized polydiorganosiloxane vinylic crosslinkers and uses thereof
WO2017103792A1 (en) 2015-12-15 2017-06-22 Novartis Ag Amphiphilic branched polydiorganosiloxane macromers
US9802339B2 (en) 2013-12-13 2017-10-31 Novartis Ag Method for making contact lenses

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602007007082D1 (en) 2006-07-12 2010-07-22 Novartis Ag Actinically crosslinkable copolymers for production of contact lenses
US7838698B2 (en) 2006-09-29 2010-11-23 Johnson & Johnson Vision Care, Inc. Hydrolysis-resistant silicone compounds
US9056880B2 (en) 2006-09-29 2015-06-16 Johnson & Johnson Vision Care, Inc. Process for producing hydrolysis-resistant silicone compounds
KR101482808B1 (en) 2007-03-22 2015-01-14 노파르티스 아게 Prepolymers with dangling polysiloxane-containing polymer chains
US7968018B2 (en) * 2007-04-18 2011-06-28 Coopervision International Holding Company, Lp Use of surfactants in extraction procedures for silicone hydrogel ophthalmic lenses
WO2010071691A1 (en) * 2008-12-18 2010-06-24 Novartis Ag Method for making silicone hydrogel contact lenses
EP2238480B1 (en) * 2007-12-20 2012-02-01 Novartis AG Method for making contact lenses
US20090171049A1 (en) * 2007-12-27 2009-07-02 Linhardt Jeffrey G Segmented reactive block copolymers
US7897654B2 (en) * 2007-12-27 2011-03-01 Johnson & Johnson Vision Care Inc. Silicone prepolymer solutions
US7981329B2 (en) * 2008-02-01 2011-07-19 National Tsing Hua University Method of manufacturing optical components
US8079703B2 (en) 2008-07-21 2011-12-20 Novartis Ag Silicone-containing polymeric materials with hydrolyzable groups
RU2524946C2 (en) * 2008-11-13 2014-08-10 Новартис Аг Polysiloxane copolymers with hydrophilic polymer terminal chains
JP5748224B2 (en) * 2008-11-13 2015-07-15 ノバルティス アーゲー Silicone hydrogel material with a chemically bound wetting agent
RU2527976C2 (en) * 2008-12-05 2014-09-10 Новартис Аг Ophthalmic devices for hydrophobic comfort-maintaining agent delivery
EP2432821B1 (en) 2009-05-22 2017-08-30 Novartis AG Actinically-crosslinkable siloxane-containing copolymers
WO2010133680A1 (en) * 2009-05-22 2010-11-25 Novartis Ag Actinically-crosslinkable siloxane-containing copolymers
CA2777961C (en) 2009-12-08 2016-03-22 Novartis Ag A silicone hydrogel lens with a covalently attached coating
EP2538266A4 (en) 2010-02-16 2014-08-27 Toray Industries Soft ocular lens having low moisture content and method for producing same
US9522980B2 (en) 2010-05-06 2016-12-20 Johnson & Johnson Vision Care, Inc. Non-reactive, hydrophilic polymers having terminal siloxanes and methods for making and using the same
CN105601930A (en) 2010-07-30 2016-05-25 诺华股份有限公司 Amphiphilic polysiloxane prepolymers and uses thereof
KR101795983B1 (en) 2010-07-30 2017-11-08 노파르티스 아게 Silicone hydrogel lenses with water-rich surfaces
JP5631655B2 (en) * 2010-08-05 2014-11-26 株式会社シード Contact lenses and a method of manufacturing the same
WO2012047964A1 (en) 2010-10-06 2012-04-12 Novartis Ag Chain-extended polysiloxane crosslinkers with dangling hydrophilic polymer chains
RU2576317C2 (en) 2010-10-06 2016-02-27 Новартис Аг Silicone-containing prepolymers subjected to water processing and versions of application thereof
WO2012047961A1 (en) 2010-10-06 2012-04-12 Novartis Ag Polymerizable chain-extended polysiloxanes with pendant hydrophilic groups
US20130203813A1 (en) 2011-05-04 2013-08-08 Johnson & Johnson Vision Care, Inc. Medical devices having homogeneous charge density and methods for making same
US9170349B2 (en) 2011-05-04 2015-10-27 Johnson & Johnson Vision Care, Inc. Medical devices having homogeneous charge density and methods for making same
CN106896422A (en) * 2011-06-09 2017-06-27 诺华股份有限公司 Silicone hydrogel lenses with nano-textured surfaces
EP2734247A1 (en) 2011-07-20 2014-05-28 Brigham Young University Hydrogel materials incorporating eluting ceragenin compound
WO2013024856A1 (en) 2011-08-17 2013-02-21 東レ株式会社 Medical device, and method for producing same
CN105739120A (en) * 2011-08-17 2016-07-06 东丽株式会社 Medical Treatment Device, Composition For Coating Solution, And Method For Manufacturing Medical Treatment Device
CN103747812A (en) 2011-08-17 2014-04-23 东丽株式会社 Medical device, and method for producing same
US9753187B2 (en) 2011-08-17 2017-09-05 Toray Industries, Inc. Low hydrous soft ophthalmic lens and method for manufacturing the same
US8932614B2 (en) 2011-08-25 2015-01-13 Paul B. Savage Incorporation of particulate ceragenins in polymers
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
EP2755661A1 (en) 2011-09-13 2014-07-23 Brigham Young University Compositions for treating bone diseases and broken bones
CA2848567A1 (en) 2011-09-13 2013-03-21 Brigham Young University Products for healing of tissue wounds
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
WO2013055746A1 (en) 2011-10-12 2013-04-18 Novartis Ag Method for making uv-absorbing ophthalmic lenses by coating
CA2855820C (en) 2011-11-15 2017-07-04 Novartis Ag A silicone hydrogel lens with a crosslinked hydrophilic coating
CA2859325A1 (en) 2011-12-21 2013-07-25 Brigham Young University Oral care compositions
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
US9244196B2 (en) 2012-05-25 2016-01-26 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
US8807745B2 (en) * 2012-05-25 2014-08-19 Bausch & Lomb Incorporated Fully polymerized UV blocking silicone hydrogel lens
EP2856218B9 (en) * 2012-05-25 2016-11-30 Bausch & Lomb Incorporated Fully polymerized uv blocking silicone hydrogel lens
US9075187B2 (en) 2012-05-25 2015-07-07 Bausch & Lomb Incorporated Fully polymerized UV blocking silicone hydrogel lens
US9297929B2 (en) 2012-05-25 2016-03-29 Johnson & Johnson Vision Care, Inc. Contact lenses comprising water soluble N-(2 hydroxyalkyl) (meth)acrylamide polymers or copolymers
US9422447B2 (en) 2012-06-14 2016-08-23 Novartis Ag Azetidinium-containing copolymers and uses thereof
WO2014062960A1 (en) 2012-10-17 2014-04-24 Brigham Young University Treatment and prevention of mastitis
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
CN105829081B (en) 2013-12-17 2017-12-19 诺华股份有限公司 Silicone having a crosslinked hydrophilic coating of hydrogel lenses
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
WO2016032926A1 (en) 2014-08-26 2016-03-03 Novartis Ag Method for applying stable coating on silicone hydrogel contact lenses
KR20170045253A (en) 2014-08-26 2017-04-26 노파르티스 아게 Poly(oxazoline-co-ethyleneimine)-epichlorohydrin copolymers and uses thereof
WO2016172553A1 (en) 2015-04-22 2016-10-27 Savage Paul B Methods for the synthesis of ceragenins
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
US9810812B2 (en) 2015-09-04 2017-11-07 Novartis Ag Method for producing contact lenses with durable lubricious coatings thereon
US20170165932A1 (en) 2015-12-15 2017-06-15 Novartis Ag Method for applying stable coating on silicone hydrogel contact lenses

Citations (133)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549747A (en) 1968-02-20 1970-12-22 Flow Pharma Inc Contact lens wetting solution and method of using same
US3639576A (en) 1968-06-19 1972-02-01 Barnes Hind Pharm Inc Resterilizing contact lens solution
US3882036A (en) 1968-04-26 1975-05-06 Flow Pharma Inc Contact lens cleaning and storing composition including nonionic surfactant, benzalkonium chloride and Na{hd 3{b EDTA
US4013576A (en) 1973-11-21 1977-03-22 Wesley-Jessen Inc. Contact lens treating composition
US4287175A (en) 1978-06-22 1981-09-01 Merck & Co., Inc. Contact lens wetting agents
US4312575A (en) 1979-09-18 1982-01-26 Peyman Gholam A Soft corneal contact lens with tightly cross-linked polymer coating and method of making same
US4323467A (en) 1980-11-24 1982-04-06 Syntex (U.S.A.) Inc. Contact lens cleaning, storing and wetting solutions
US4444711A (en) 1981-12-21 1984-04-24 Husky Injection Molding Systems Ltd. Method of operating a two-shot injection-molding machine
US4460534A (en) 1982-09-07 1984-07-17 International Business Machines Corporation Two-shot injection molding
US4500441A (en) 1981-05-13 1985-02-19 Toyo Contact Lens Co., Ltd. Contact lens cleaning and storage composition
US4529535A (en) 1982-06-01 1985-07-16 Sherman Laboratories, Inc. Soft contact lens wetting solution containing preservative system and method
US4536554A (en) 1984-02-22 1985-08-20 Barnes-Hind, Inc. Hydrophilic polymers and contact lenses made therefrom
US4551461A (en) 1982-06-01 1985-11-05 Sherman Laboratories, Inc. Soft contact lens ambient temperature disinfectant and rinsing solution and method
US4568517A (en) 1983-08-25 1986-02-04 Barnes-Hind, Inc. Disinfection of contact lenses
US4626292A (en) 1982-06-01 1986-12-02 Sherman Laboratories, Inc. Soft contact lens wetting and preservation method
US4632844A (en) 1984-02-04 1986-12-30 Japan Synthetic Rubber Co., Ltd. Optical product having a thin film on the surface
US4746514A (en) 1984-09-11 1988-05-24 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Hydrogel materials formed by radiation polymerization of carbohydrates and unsaturated monomers
US4783488A (en) 1987-01-31 1988-11-08 Bausch & Lomb Incorporated Contact lens wetting solution
US4786436A (en) 1986-01-31 1988-11-22 Bausch & Lomb Incorporated Wetting solutions for contact lenses
EP0139994B1 (en) 1983-08-25 1989-05-03 Allergan, Inc. Process and kit for disinfection of contact lenses
EP0315836A2 (en) 1987-10-30 1989-05-17 HÜLS AMERICA INC. (a Delaware corporation) Polyorganosiloxane based interpenetrating network polymers and methods of making
US4983702A (en) 1988-09-28 1991-01-08 Ciba-Geigy Corporation Crosslinked siloxane-urethane polymer contact lens
US5008356A (en) 1987-03-02 1991-04-16 Mitsui Petrochemical Industries, Ltd. Cyclo-olefinic random copolymer, olefinic random copolymer, and process for producing cyclo-olefinic random copolymers
US5036971A (en) 1987-01-27 1991-08-06 Coopervision Optics, Ltd. Moulding contact lenses
US5087392A (en) 1988-05-31 1992-02-11 Sola Usa, Inc. Method of mold contact lenses
US5087677A (en) 1989-07-08 1992-02-11 Hoechst Aktiengesellschaft Process for the preparation of cycloolefin polymers
US5141665A (en) 1987-03-31 1992-08-25 Sherman Laboratories, Inc. Cleaning, conditioning, storing and wetting system and method for rigid gas permeable contact lenses and other contact lenses
US5157093A (en) 1990-05-10 1992-10-20 Ciba-Geigy Corporation Hydroxyethyl cellulose derivatives containing pendant (meth)acryloyl units bound through urethane groups and hydrogel contact lenses made therefrom
US5198477A (en) 1991-02-28 1993-03-30 Ciba-Geigy Corporation Contact lenses made from thermoformable material
US5260001A (en) 1992-08-03 1993-11-09 Bausch & Lomb Incorporated Spincasting process for producing a series of contact lenses having desired shapes
US5322667A (en) 1987-03-31 1994-06-21 Sherman Pharmaceuticals, Inc. Preservative system for ophthalmic and contact lens solutions and method for cleaning disinfecting and storing contact lenses
US5364601A (en) 1992-12-30 1994-11-15 Bausch & Lomb Incorporated Treating of contact lenses with compositions comprising PVP-H202
US5382599A (en) 1993-10-13 1995-01-17 Allergan, Inc. Method of inhibiting protozoan growth in eye care products using a polyvalent cation chelating agent
US5405878A (en) 1993-06-18 1995-04-11 Wilmington Partners L.P. Contact lens solution containing cationic glycoside
US5500144A (en) 1993-06-18 1996-03-19 Polymer Technology Corporation Composition for cleaning and wetting contact lenses
US5508317A (en) 1993-08-06 1996-04-16 Ciba-Geigy Corporation Photocrosslinked polymers
US5583463A (en) 1995-05-30 1996-12-10 Micron Technology, Inc. Redundant row fuse bank circuit
US5604189A (en) 1993-06-18 1997-02-18 Zhang; Hong J. Composition for cleaning and wetting contact lenses
US5656210A (en) 1995-03-31 1997-08-12 Johnson & Johnson Vision Products, Inc. Reaction injection molding as a process to prepare contact lenses
US5665840A (en) 1994-11-18 1997-09-09 Novartis Corporation Polymeric networks from water-soluble prepolymers
US5711823A (en) 1993-06-18 1998-01-27 Wilmington Partners L.P. Method for wetting contact lenses
US5712356A (en) 1993-11-26 1998-01-27 Ciba Vision Corporation Cross-linkable copolymers and hydrogels
US5726733A (en) 1993-12-21 1998-03-10 Bausch & Lomb Incorporated Method for increasing hydrophilicity of contact lenses
US5731087A (en) 1995-06-07 1998-03-24 Union Carbide Chemicals & Plastics Technology Corporation Lubricious coatings containing polymers with vinyl and carboxylic acid moieties
US5760100A (en) 1994-09-06 1998-06-02 Ciba Vision Corporation Extended wear ophthalmic lens
US5800412A (en) 1996-10-10 1998-09-01 Sts Biopolymers, Inc. Hydrophilic coatings with hydrating agents
US5807636A (en) 1994-12-16 1998-09-15 Advanced Surface Technology Durable hydrophilic surface coatings
US5843346A (en) 1994-06-30 1998-12-01 Polymer Technology Corporation Method of cast molding contact lenses
US5849841A (en) 1995-02-03 1998-12-15 Ciba Vision Corporation Crosslinked polymers containing ester or amide groups
US5882687A (en) 1997-01-10 1999-03-16 Allergan Compositions and methods for storing contact lenses
US5894002A (en) 1993-12-13 1999-04-13 Ciba Vision Corporation Process and apparatus for the manufacture of a contact lens
US5942558A (en) 1995-03-24 1999-08-24 Ocular Research Of Boston, Inc. Hydrogel lens pre-coated with lipid layer
EP0940693A2 (en) 1998-03-02 1999-09-08 Johnson &amp; Johnson Vision Products, Inc. Soft contact lenses
US6037328A (en) 1998-12-22 2000-03-14 Bausch & Lomb Incorporated Method and composition for rewetting and preventing deposits on contact lens
US6039913A (en) 1998-08-27 2000-03-21 Novartis Ag Process for the manufacture of an ophthalmic molding
US6165408A (en) 1997-02-04 2000-12-26 Novartis Ag Moulded ophthalmic article
US6193369B1 (en) 1998-05-05 2001-02-27 Bausch & Lomb Incorporated Plasma surface treatment of silicone hydrogel contact lenses
US6207628B1 (en) 1997-05-05 2001-03-27 Essilor International Compagnie Generale D'optique Aqueous solution
WO2001020997A1 (en) 1999-09-20 2001-03-29 Menicon Co., Ltd. Liquid preparation for contact lenses
WO2001027174A1 (en) 1999-10-07 2001-04-19 Johnson & Johnson Vision Care, Inc. Soft contact lenses
US6221303B1 (en) 1997-02-21 2001-04-24 Novartis Ag Ophthalmic mouldings
WO2001034312A1 (en) 1999-11-05 2001-05-17 Bausch & Lomb Incorporated Surface treatment of non-plasma treated silicone hydrogel contact lenses
US6274133B1 (en) 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Method for treating extended-wear contact lenses in the eyes
WO2001070837A1 (en) 2000-03-22 2001-09-27 Johnson & Johnson Vision Care, Inc. Hydrogel with internal wetting agent
US6303687B1 (en) 1995-02-03 2001-10-16 Novartis Ag Crosslinked polymers containing salt structures
US20010044482A1 (en) 1998-07-08 2001-11-22 Hopin Hu Interpenetrating polymer network hydrophilic hydrogels for contact lens
US6348507B1 (en) 1998-05-05 2002-02-19 Bausch & Lomb Incorporated Surface treatment of silicone hydrogel contact lenses
WO2002038161A1 (en) 2000-11-08 2002-05-16 Bio-Concept Laboratories Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US20020071789A1 (en) 2000-12-07 2002-06-13 Molock Frank F. Contact lens packaging solutions
US6428839B1 (en) 2000-06-02 2002-08-06 Bausch & Lomb Incorporated Surface treatment of medical device
US20020115578A1 (en) 2000-12-14 2002-08-22 Groemminger Suzanne F. Composition for cleaning and wetting contact lenses
US6440366B1 (en) 1997-06-06 2002-08-27 Bausch & Lomb Incorporated Contact lens packing solutions
US6451871B1 (en) 1998-11-25 2002-09-17 Novartis Ag Methods of modifying surface characteristics
US6472489B1 (en) 1998-11-20 2002-10-29 Novartis Ag Polymers
US6479587B1 (en) 1997-09-16 2002-11-12 Novartis Ag Crosslinkable polyurea polymers
US6482799B1 (en) 1999-05-25 2002-11-19 The Regents Of The University Of California Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial
US20020182315A1 (en) 2000-11-01 2002-12-05 Heiler David J. Surface treatment of non-plasma treated silicone hydrogel contact lenses
US6492478B1 (en) 1996-10-21 2002-12-10 Novartis Ag Polymers with crosslinkable pendent groups
US6528048B1 (en) 1998-11-16 2003-03-04 Rohto Pharmaceutical Co., Ltd. Ophthalmic solutions
US20030052424A1 (en) 2001-08-02 2003-03-20 Turner David C. Method for coating articles by mold transfer
US20030096717A1 (en) 2001-08-17 2003-05-22 Bausch & Lomb Incorporated Composition and method for inhibiting uptake of biguanide antimicrobials by hydrogels
US20030095230A1 (en) 2001-08-02 2003-05-22 Neely Frank L. Antimicrobial lenses and methods of their use related patent applications
US20030117579A1 (en) 2001-11-14 2003-06-26 Morris Carol Ann Medical devices having antimicrobial coatings thereon
US20030125498A1 (en) 2001-09-10 2003-07-03 Mccabe Kevin P. Biomedical devices containing internal wetting agents
US6589665B2 (en) 2000-05-30 2003-07-08 Novartis Ag Coated articles
US20030130144A1 (en) 2000-12-07 2003-07-10 Nayiby Alvarez Methods of inhibiting the adherence of lenses to their packaging
US20030162862A1 (en) 2001-09-10 2003-08-28 Mccabe Kevin P. Biomedical devices containing internal wetting agents
US6617291B1 (en) 2001-11-08 2003-09-09 Francis X. Smith Ophthalmic and contact lens solutions
US6627124B1 (en) 1997-10-21 2003-09-30 Novartis Ag Single mould alignment
US6630243B2 (en) 1999-05-20 2003-10-07 Bausch & Lomb Incorporated Surface treatment of silicone hydrogel contact lenses comprising hydrophilic polymer chains attached to an intermediate carbon coating
US6634748B1 (en) 2000-11-15 2003-10-21 Johnson & Johnson Vision Care, Inc. Methods of stabilizing silicone hydrogels against hydrolytic degradation
US20030219909A1 (en) 2002-03-13 2003-11-27 Lally John Martin Materials containing multiple layers of vesicles
US6686330B2 (en) 1999-12-08 2004-02-03 The Procter & Gamble Company Compositions including ether-capped poly (oxyalkylated) alcohol wetting agents
US6689480B2 (en) 2000-05-10 2004-02-10 Toray Industries, Inc. Surface-treated plastic article and method of surface treatment
US20040028645A1 (en) 2001-12-13 2004-02-12 Masood Chowhan Artificial tear composition adapted to be used with contact lenses
US6702983B2 (en) 2001-05-15 2004-03-09 Bausch & Lomb Incorporated Low ionic strength method and composition for reducing bacterial attachment to biomaterials
US6719929B2 (en) 2000-02-04 2004-04-13 Novartis Ag Method for modifying a surface
US20040115270A1 (en) 2002-12-13 2004-06-17 Dharmendra Jani Absorption and controlled release of polyethers from hydrogel biomaterials
US20040119176A1 (en) 2002-12-23 2004-06-24 Bausch & Lomb Incorporated Method for manufacturing lenses
US20040120982A1 (en) 2002-12-19 2004-06-24 Zanini Diana Biomedical devices with coatings attached via latent reactive components
US6759491B2 (en) 2001-10-12 2004-07-06 Carnegie Mellon University Simultaneous reverse and normal initiation of ATRP
US20040135967A1 (en) 2002-12-03 2004-07-15 Carney Fiona Patricia Medical devices having antimicrobial coatings thereon
US6793973B2 (en) 2000-02-04 2004-09-21 Novartis Ag Single-dip process for achieving a layer-by-layer-like coating
US20040186248A1 (en) 1998-03-02 2004-09-23 Vanderlaan Douglas G. Soft contact lenses
US6805836B2 (en) 2000-12-15 2004-10-19 Bausch & Lomb Incorporated Prevention of preservative uptake into biomaterials
US6811805B2 (en) 2001-05-30 2004-11-02 Novatis Ag Method for applying a coating
US6815074B2 (en) 2001-05-30 2004-11-09 Novartis Ag Polymeric materials for making contact lenses
US6827966B2 (en) 2001-05-30 2004-12-07 Novartis Ag Diffusion-controllable coatings on medical device
US20050008676A1 (en) 2002-12-19 2005-01-13 Yongxing Qiu Medical devices having antimicrobial coatings thereon
US20050006255A1 (en) 2002-12-23 2005-01-13 Peck James M. Contact lens packages containing additives
US20050013842A1 (en) 2003-07-16 2005-01-20 Yongxing Qiu Antimicrobial medical devices
US6849671B2 (en) 1998-03-02 2005-02-01 Johnson & Johnson Vision Care, Inc. Contact lenses
US6852353B2 (en) 2000-08-24 2005-02-08 Novartis Ag Process for surface modifying substrates and modified substrates resulting therefrom
US20050047270A1 (en) 1997-10-24 2005-03-03 Wood Anthony B. System and method for therapeutic application of dissolved oxygen
US20050085591A1 (en) 2001-10-11 2005-04-21 Albertus Dozeman Process for the preparation of a dynamically vulcanized thermoplastic elastomer
US6893685B2 (en) 2000-08-24 2005-05-17 Novartis Ag Process for surface modifying substrates and modified substrates resulting therefrom
US6896926B2 (en) 2002-09-11 2005-05-24 Novartis Ag Method for applying an LbL coating onto a medical device
US20050113549A1 (en) 2003-11-25 2005-05-26 Devlin Brian G. Crosslinkable polyurea prepolymers
US20050117112A1 (en) 2003-11-18 2005-06-02 Alvarez-Carrigan Nayiby Antimicrobial lenses, processes to prepare them and methods of their use
US20050134795A1 (en) 2003-12-19 2005-06-23 Lally John M. Method for producing tinted contact lenses
US20050153056A1 (en) 2002-01-09 2005-07-14 Winterton Lynn C. Method for applying lubricious coating to a polymeric article
US6926965B2 (en) 2002-09-11 2005-08-09 Novartis Ag LbL-coated medical device and method for making the same
US20060001184A1 (en) 2004-06-30 2006-01-05 Phelan John C Method for lathing silicone hydrogel lenses
US6995192B2 (en) 2002-08-14 2006-02-07 Novartis Ag Radiation-curable prepolymers
US20060063852A1 (en) 2004-08-27 2006-03-23 Asahikasei Aime Co. Ltd. Silicone hydrogel contact lens
US20060074208A1 (en) 2004-09-30 2006-04-06 Laredo Walter R Biomedical devices containing amphiphilic block copolymers
US20060073185A1 (en) 2002-12-13 2006-04-06 Bausch & Lomb Incorporated Method and composition for contact lenses
US7091283B2 (en) 2000-03-24 2006-08-15 Novartis Ag Crosslinkable prepolymers from a hydrophilic monomer and a hydrophobic crosslinker
US20070010595A1 (en) 2005-02-14 2007-01-11 Mccabe Kevin P Comfortable ophthalmic device and methods of its production
US20070043140A1 (en) 1998-03-02 2007-02-22 Lorenz Kathrine O Method for the mitigation of symptoms of contact lens related dry eye
US20070098818A1 (en) 2000-11-08 2007-05-03 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US20080015315A1 (en) 2006-07-12 2008-01-17 Frank Chang Novel Polymers
US20080045612A1 (en) 2004-03-05 2008-02-21 Osman Rathore Wettable hydrogels comprising acyclic polyamides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0362137A3 (en) * 1988-09-28 1991-09-04 Ciba-Geigy Ag Molded polymers with hydrophilic surfaces, and process for making them
US6207328B1 (en) * 1999-08-23 2001-03-27 United Microelectronics Corp. Method of forming a phase shift mask

Patent Citations (165)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549747A (en) 1968-02-20 1970-12-22 Flow Pharma Inc Contact lens wetting solution and method of using same
US3882036A (en) 1968-04-26 1975-05-06 Flow Pharma Inc Contact lens cleaning and storing composition including nonionic surfactant, benzalkonium chloride and Na{hd 3{b EDTA
US3639576A (en) 1968-06-19 1972-02-01 Barnes Hind Pharm Inc Resterilizing contact lens solution
US4013576A (en) 1973-11-21 1977-03-22 Wesley-Jessen Inc. Contact lens treating composition
US4287175A (en) 1978-06-22 1981-09-01 Merck & Co., Inc. Contact lens wetting agents
US4312575A (en) 1979-09-18 1982-01-26 Peyman Gholam A Soft corneal contact lens with tightly cross-linked polymer coating and method of making same
US4323467A (en) 1980-11-24 1982-04-06 Syntex (U.S.A.) Inc. Contact lens cleaning, storing and wetting solutions
US4500441A (en) 1981-05-13 1985-02-19 Toyo Contact Lens Co., Ltd. Contact lens cleaning and storage composition
US4444711A (en) 1981-12-21 1984-04-24 Husky Injection Molding Systems Ltd. Method of operating a two-shot injection-molding machine
US4626292A (en) 1982-06-01 1986-12-02 Sherman Laboratories, Inc. Soft contact lens wetting and preservation method
US4529535A (en) 1982-06-01 1985-07-16 Sherman Laboratories, Inc. Soft contact lens wetting solution containing preservative system and method
US4560491A (en) 1982-06-01 1985-12-24 Sherman Laboratories, Inc. Soft contact lens wetting solution and in-eye comfort solution containing preservative and method
US4551461A (en) 1982-06-01 1985-11-05 Sherman Laboratories, Inc. Soft contact lens ambient temperature disinfectant and rinsing solution and method
US4460534A (en) 1982-09-07 1984-07-17 International Business Machines Corporation Two-shot injection molding
US4568517A (en) 1983-08-25 1986-02-04 Barnes-Hind, Inc. Disinfection of contact lenses
EP0139994B2 (en) 1983-08-25 1995-11-29 Allergan, Inc. Process and kit for disinfection of contact lenses
EP0139994B1 (en) 1983-08-25 1989-05-03 Allergan, Inc. Process and kit for disinfection of contact lenses
US4632844A (en) 1984-02-04 1986-12-30 Japan Synthetic Rubber Co., Ltd. Optical product having a thin film on the surface
US4536554A (en) 1984-02-22 1985-08-20 Barnes-Hind, Inc. Hydrophilic polymers and contact lenses made therefrom
US4746514A (en) 1984-09-11 1988-05-24 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Hydrogel materials formed by radiation polymerization of carbohydrates and unsaturated monomers
US4786436A (en) 1986-01-31 1988-11-22 Bausch & Lomb Incorporated Wetting solutions for contact lenses
US5036971A (en) 1987-01-27 1991-08-06 Coopervision Optics, Ltd. Moulding contact lenses
US4783488A (en) 1987-01-31 1988-11-08 Bausch & Lomb Incorporated Contact lens wetting solution
US5008356A (en) 1987-03-02 1991-04-16 Mitsui Petrochemical Industries, Ltd. Cyclo-olefinic random copolymer, olefinic random copolymer, and process for producing cyclo-olefinic random copolymers
US5322667A (en) 1987-03-31 1994-06-21 Sherman Pharmaceuticals, Inc. Preservative system for ophthalmic and contact lens solutions and method for cleaning disinfecting and storing contact lenses
US5141665A (en) 1987-03-31 1992-08-25 Sherman Laboratories, Inc. Cleaning, conditioning, storing and wetting system and method for rigid gas permeable contact lenses and other contact lenses
EP0315836A2 (en) 1987-10-30 1989-05-17 HÜLS AMERICA INC. (a Delaware corporation) Polyorganosiloxane based interpenetrating network polymers and methods of making
US5087392A (en) 1988-05-31 1992-02-11 Sola Usa, Inc. Method of mold contact lenses
US4983702A (en) 1988-09-28 1991-01-08 Ciba-Geigy Corporation Crosslinked siloxane-urethane polymer contact lens
US5087677A (en) 1989-07-08 1992-02-11 Hoechst Aktiengesellschaft Process for the preparation of cycloolefin polymers
US5157093A (en) 1990-05-10 1992-10-20 Ciba-Geigy Corporation Hydroxyethyl cellulose derivatives containing pendant (meth)acryloyl units bound through urethane groups and hydrogel contact lenses made therefrom
US5198477A (en) 1991-02-28 1993-03-30 Ciba-Geigy Corporation Contact lenses made from thermoformable material
US5260001A (en) 1992-08-03 1993-11-09 Bausch & Lomb Incorporated Spincasting process for producing a series of contact lenses having desired shapes
US5364601A (en) 1992-12-30 1994-11-15 Bausch & Lomb Incorporated Treating of contact lenses with compositions comprising PVP-H202
US5604189A (en) 1993-06-18 1997-02-18 Zhang; Hong J. Composition for cleaning and wetting contact lenses
US5773396A (en) 1993-06-18 1998-06-30 Polymer Technology Corporation Contact lens cleaning and wetting solutions containing a non-amine polyethyleneocy adduct having a HLB value of at least about 18, a surface active agent having a HLB of less than 18, and wetting agent
US5711823A (en) 1993-06-18 1998-01-27 Wilmington Partners L.P. Method for wetting contact lenses
US5500144A (en) 1993-06-18 1996-03-19 Polymer Technology Corporation Composition for cleaning and wetting contact lenses
US5872086A (en) 1993-06-18 1999-02-16 Wilmington Partners Lp Composition for wetting contact lenses
US5405878A (en) 1993-06-18 1995-04-11 Wilmington Partners L.P. Contact lens solution containing cationic glycoside
US5849810A (en) 1993-08-06 1998-12-15 Ciba Vision Corporation Photocrosslinked polymers
US5789464A (en) 1993-08-06 1998-08-04 Ciba Vision Corporation Photocrosslinked polymers
US5508317A (en) 1993-08-06 1996-04-16 Ciba-Geigy Corporation Photocrosslinked polymers
US5382599A (en) 1993-10-13 1995-01-17 Allergan, Inc. Method of inhibiting protozoan growth in eye care products using a polyvalent cation chelating agent
US5936052A (en) 1993-11-26 1999-08-10 Ciba Vision Corporation Cross-linkable copolymers and hydrogels
US5712356A (en) 1993-11-26 1998-01-27 Ciba Vision Corporation Cross-linkable copolymers and hydrogels
US5894002A (en) 1993-12-13 1999-04-13 Ciba Vision Corporation Process and apparatus for the manufacture of a contact lens
US5726733A (en) 1993-12-21 1998-03-10 Bausch & Lomb Incorporated Method for increasing hydrophilicity of contact lenses
US5843346A (en) 1994-06-30 1998-12-01 Polymer Technology Corporation Method of cast molding contact lenses
US5760100B1 (en) 1994-09-06 2000-11-14 Ciba Vision Corp Extended wear ophthalmic lens
US5760100A (en) 1994-09-06 1998-06-02 Ciba Vision Corporation Extended wear ophthalmic lens
US5665840A (en) 1994-11-18 1997-09-09 Novartis Corporation Polymeric networks from water-soluble prepolymers
US5837377A (en) 1994-12-16 1998-11-17 Advanced Surface Technology, Inc. Biomedical articles with ionically bonded polyelectrolyte coatings
US5807636A (en) 1994-12-16 1998-09-15 Advanced Surface Technology Durable hydrophilic surface coatings
US5849841A (en) 1995-02-03 1998-12-15 Ciba Vision Corporation Crosslinked polymers containing ester or amide groups
US6303687B1 (en) 1995-02-03 2001-10-16 Novartis Ag Crosslinked polymers containing salt structures
US5942558A (en) 1995-03-24 1999-08-24 Ocular Research Of Boston, Inc. Hydrogel lens pre-coated with lipid layer
US5656210A (en) 1995-03-31 1997-08-12 Johnson & Johnson Vision Products, Inc. Reaction injection molding as a process to prepare contact lenses
US5583463A (en) 1995-05-30 1996-12-10 Micron Technology, Inc. Redundant row fuse bank circuit
US5731087A (en) 1995-06-07 1998-03-24 Union Carbide Chemicals & Plastics Technology Corporation Lubricious coatings containing polymers with vinyl and carboxylic acid moieties
US5800412A (en) 1996-10-10 1998-09-01 Sts Biopolymers, Inc. Hydrophilic coatings with hydrating agents
US6492478B1 (en) 1996-10-21 2002-12-10 Novartis Ag Polymers with crosslinkable pendent groups
US5882687A (en) 1997-01-10 1999-03-16 Allergan Compositions and methods for storing contact lenses
US6165408A (en) 1997-02-04 2000-12-26 Novartis Ag Moulded ophthalmic article
US6221303B1 (en) 1997-02-21 2001-04-24 Novartis Ag Ophthalmic mouldings
US6207628B1 (en) 1997-05-05 2001-03-27 Essilor International Compagnie Generale D'optique Aqueous solution
US6440366B1 (en) 1997-06-06 2002-08-27 Bausch & Lomb Incorporated Contact lens packing solutions
US6699435B2 (en) 1997-06-06 2004-03-02 Bausch & Lomb Incorporated Contact lens packing solutions
US6479587B1 (en) 1997-09-16 2002-11-12 Novartis Ag Crosslinkable polyurea polymers
US6627124B1 (en) 1997-10-21 2003-09-30 Novartis Ag Single mould alignment
US20050047270A1 (en) 1997-10-24 2005-03-03 Wood Anthony B. System and method for therapeutic application of dissolved oxygen
US6849671B2 (en) 1998-03-02 2005-02-01 Johnson & Johnson Vision Care, Inc. Contact lenses
US20070043140A1 (en) 1998-03-02 2007-02-22 Lorenz Kathrine O Method for the mitigation of symptoms of contact lens related dry eye
US5998498A (en) 1998-03-02 1999-12-07 Johnson & Johnson Vision Products, Inc. Soft contact lenses
EP0940693A2 (en) 1998-03-02 1999-09-08 Johnson &amp; Johnson Vision Products, Inc. Soft contact lenses
US20040186248A1 (en) 1998-03-02 2004-09-23 Vanderlaan Douglas G. Soft contact lenses
US6943203B2 (en) 1998-03-02 2005-09-13 Johnson & Johnson Vision Care, Inc. Soft contact lenses
US6367929B1 (en) 1998-03-02 2002-04-09 Johnson & Johnson Vision Care, Inc. Hydrogel with internal wetting agent
US6348507B1 (en) 1998-05-05 2002-02-19 Bausch & Lomb Incorporated Surface treatment of silicone hydrogel contact lenses
US6193369B1 (en) 1998-05-05 2001-02-27 Bausch & Lomb Incorporated Plasma surface treatment of silicone hydrogel contact lenses
US20010044482A1 (en) 1998-07-08 2001-11-22 Hopin Hu Interpenetrating polymer network hydrophilic hydrogels for contact lens
US7279507B2 (en) 1998-07-08 2007-10-09 Coopervision International Holding Company, Lp Contact lenses
US6039913A (en) 1998-08-27 2000-03-21 Novartis Ag Process for the manufacture of an ophthalmic molding
US6528048B1 (en) 1998-11-16 2003-03-04 Rohto Pharmaceutical Co., Ltd. Ophthalmic solutions
US6472489B1 (en) 1998-11-20 2002-10-29 Novartis Ag Polymers
US6451871B1 (en) 1998-11-25 2002-09-17 Novartis Ag Methods of modifying surface characteristics
US6274133B1 (en) 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Method for treating extended-wear contact lenses in the eyes
US6037328A (en) 1998-12-22 2000-03-14 Bausch & Lomb Incorporated Method and composition for rewetting and preventing deposits on contact lens
EP1187873B1 (en) 1999-05-20 2004-09-15 BAUSCH &amp; LOMB INCORPORATED Surface treatment of silicone hydrogel contact lenses comprising hydrophilic polymer chains attached to an intermediate carbon coating
US6630243B2 (en) 1999-05-20 2003-10-07 Bausch & Lomb Incorporated Surface treatment of silicone hydrogel contact lenses comprising hydrophilic polymer chains attached to an intermediate carbon coating
US6902812B2 (en) 1999-05-20 2005-06-07 Bausch & Lomb Incorporated Surface treatment for silicone hydrogel contact lenses comprising hydrophilic polymer chains attached to an intermediate carbon coating
US6482799B1 (en) 1999-05-25 2002-11-19 The Regents Of The University Of California Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial
WO2001020997A1 (en) 1999-09-20 2001-03-29 Menicon Co., Ltd. Liquid preparation for contact lenses
US7364723B1 (en) 1999-09-20 2008-04-29 Menicon Co., Ltd. Liquid preparation for contact lenses
WO2001027174A1 (en) 1999-10-07 2001-04-19 Johnson & Johnson Vision Care, Inc. Soft contact lenses
WO2001034312A1 (en) 1999-11-05 2001-05-17 Bausch & Lomb Incorporated Surface treatment of non-plasma treated silicone hydrogel contact lenses
US6686330B2 (en) 1999-12-08 2004-02-03 The Procter & Gamble Company Compositions including ether-capped poly (oxyalkylated) alcohol wetting agents
US6793973B2 (en) 2000-02-04 2004-09-21 Novartis Ag Single-dip process for achieving a layer-by-layer-like coating
US6719929B2 (en) 2000-02-04 2004-04-13 Novartis Ag Method for modifying a surface
WO2001070837A1 (en) 2000-03-22 2001-09-27 Johnson & Johnson Vision Care, Inc. Hydrogel with internal wetting agent
US7238750B2 (en) 2000-03-24 2007-07-03 Novartis Ag Polymers
US7268189B2 (en) 2000-03-24 2007-09-11 Novartis Ag Polymers
US20080021127A1 (en) 2000-03-24 2008-01-24 Beat Muller Novel polymers
US7091283B2 (en) 2000-03-24 2006-08-15 Novartis Ag Crosslinkable prepolymers from a hydrophilic monomer and a hydrophobic crosslinker
US6689480B2 (en) 2000-05-10 2004-02-10 Toray Industries, Inc. Surface-treated plastic article and method of surface treatment
US6589665B2 (en) 2000-05-30 2003-07-08 Novartis Ag Coated articles
US6428839B1 (en) 2000-06-02 2002-08-06 Bausch & Lomb Incorporated Surface treatment of medical device
US6852353B2 (en) 2000-08-24 2005-02-08 Novartis Ag Process for surface modifying substrates and modified substrates resulting therefrom
US6893685B2 (en) 2000-08-24 2005-05-17 Novartis Ag Process for surface modifying substrates and modified substrates resulting therefrom
US20020182315A1 (en) 2000-11-01 2002-12-05 Heiler David J. Surface treatment of non-plasma treated silicone hydrogel contact lenses
WO2002038161A1 (en) 2000-11-08 2002-05-16 Bio-Concept Laboratories Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US20060142169A1 (en) 2000-11-08 2006-06-29 Bioconcept Laboratories Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US20070098818A1 (en) 2000-11-08 2007-05-03 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US6634748B1 (en) 2000-11-15 2003-10-21 Johnson & Johnson Vision Care, Inc. Methods of stabilizing silicone hydrogels against hydrolytic degradation
US6867172B2 (en) 2000-12-07 2005-03-15 Johnson & Johnson Vision Care, Inc. Methods of inhibiting the adherence of lenses to their packaging
US20020071789A1 (en) 2000-12-07 2002-06-13 Molock Frank F. Contact lens packaging solutions
US6531432B2 (en) 2000-12-07 2003-03-11 Johnson & Johnson Vision Care, Inc. Contact lens packaging solutions
US20030130144A1 (en) 2000-12-07 2003-07-10 Nayiby Alvarez Methods of inhibiting the adherence of lenses to their packaging
US20020115578A1 (en) 2000-12-14 2002-08-22 Groemminger Suzanne F. Composition for cleaning and wetting contact lenses
US6805836B2 (en) 2000-12-15 2004-10-19 Bausch & Lomb Incorporated Prevention of preservative uptake into biomaterials
US6702983B2 (en) 2001-05-15 2004-03-09 Bausch & Lomb Incorporated Low ionic strength method and composition for reducing bacterial attachment to biomaterials
US6811805B2 (en) 2001-05-30 2004-11-02 Novatis Ag Method for applying a coating
US6815074B2 (en) 2001-05-30 2004-11-09 Novartis Ag Polymeric materials for making contact lenses
US6827966B2 (en) 2001-05-30 2004-12-07 Novartis Ag Diffusion-controllable coatings on medical device
US20030095230A1 (en) 2001-08-02 2003-05-22 Neely Frank L. Antimicrobial lenses and methods of their use related patent applications
US20030052424A1 (en) 2001-08-02 2003-03-20 Turner David C. Method for coating articles by mold transfer
US20030096717A1 (en) 2001-08-17 2003-05-22 Bausch & Lomb Incorporated Composition and method for inhibiting uptake of biguanide antimicrobials by hydrogels
US7052131B2 (en) 2001-09-10 2006-05-30 J&J Vision Care, Inc. Biomedical devices containing internal wetting agents
US20030162862A1 (en) 2001-09-10 2003-08-28 Mccabe Kevin P. Biomedical devices containing internal wetting agents
US6822016B2 (en) 2001-09-10 2004-11-23 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US20030125498A1 (en) 2001-09-10 2003-07-03 Mccabe Kevin P. Biomedical devices containing internal wetting agents
US20050154080A1 (en) 2001-09-10 2005-07-14 Mccabe Kevin P. Biomedical devices containing internal wetting agents
US20050085591A1 (en) 2001-10-11 2005-04-21 Albertus Dozeman Process for the preparation of a dynamically vulcanized thermoplastic elastomer
US6759491B2 (en) 2001-10-12 2004-07-06 Carnegie Mellon University Simultaneous reverse and normal initiation of ATRP
US6617291B1 (en) 2001-11-08 2003-09-09 Francis X. Smith Ophthalmic and contact lens solutions
US20030117579A1 (en) 2001-11-14 2003-06-26 Morris Carol Ann Medical devices having antimicrobial coatings thereon
US20040028645A1 (en) 2001-12-13 2004-02-12 Masood Chowhan Artificial tear composition adapted to be used with contact lenses
US20050153056A1 (en) 2002-01-09 2005-07-14 Winterton Lynn C. Method for applying lubricious coating to a polymeric article
US20030219909A1 (en) 2002-03-13 2003-11-27 Lally John Martin Materials containing multiple layers of vesicles
US7329415B2 (en) 2002-03-13 2008-02-12 Novartis Ag Materials containing multiple layers of vesicles
US6995192B2 (en) 2002-08-14 2006-02-07 Novartis Ag Radiation-curable prepolymers
US6926965B2 (en) 2002-09-11 2005-08-09 Novartis Ag LbL-coated medical device and method for making the same
US6896926B2 (en) 2002-09-11 2005-05-24 Novartis Ag Method for applying an LbL coating onto a medical device
US20040135967A1 (en) 2002-12-03 2004-07-15 Carney Fiona Patricia Medical devices having antimicrobial coatings thereon
US20040115270A1 (en) 2002-12-13 2004-06-17 Dharmendra Jani Absorption and controlled release of polyethers from hydrogel biomaterials
US20060073185A1 (en) 2002-12-13 2006-04-06 Bausch & Lomb Incorporated Method and composition for contact lenses
US20050058844A1 (en) 2002-12-19 2005-03-17 Rubner Michael F. Method for making medical devices having antimicrobial coatings thereon
US20040120982A1 (en) 2002-12-19 2004-06-24 Zanini Diana Biomedical devices with coatings attached via latent reactive components
US20050008676A1 (en) 2002-12-19 2005-01-13 Yongxing Qiu Medical devices having antimicrobial coatings thereon
US20040119176A1 (en) 2002-12-23 2004-06-24 Bausch & Lomb Incorporated Method for manufacturing lenses
US20050006255A1 (en) 2002-12-23 2005-01-13 Peck James M. Contact lens packages containing additives
US20050013842A1 (en) 2003-07-16 2005-01-20 Yongxing Qiu Antimicrobial medical devices
WO2005014074A1 (en) 2003-07-16 2005-02-17 Novartis Ag Antimicrobial medical devices
US20050117112A1 (en) 2003-11-18 2005-06-02 Alvarez-Carrigan Nayiby Antimicrobial lenses, processes to prepare them and methods of their use
US20050113549A1 (en) 2003-11-25 2005-05-26 Devlin Brian G. Crosslinkable polyurea prepolymers
US20050134795A1 (en) 2003-12-19 2005-06-23 Lally John M. Method for producing tinted contact lenses
US7165839B2 (en) 2003-12-19 2007-01-23 Novartis Ag Method for producing tinted contact lenses
US20080045612A1 (en) 2004-03-05 2008-02-21 Osman Rathore Wettable hydrogels comprising acyclic polyamides
US20060001184A1 (en) 2004-06-30 2006-01-05 Phelan John C Method for lathing silicone hydrogel lenses
WO2006002894A1 (en) 2004-06-30 2006-01-12 Novartis Ag Method for lathing silicone hydrogel lenses
US20060063852A1 (en) 2004-08-27 2006-03-23 Asahikasei Aime Co. Ltd. Silicone hydrogel contact lens
US7247692B2 (en) 2004-09-30 2007-07-24 Johnson & Johnson Vision Care, Inc. Biomedical devices containing amphiphilic block copolymers
US20060074208A1 (en) 2004-09-30 2006-04-06 Laredo Walter R Biomedical devices containing amphiphilic block copolymers
US20070010595A1 (en) 2005-02-14 2007-01-11 Mccabe Kevin P Comfortable ophthalmic device and methods of its production
US20080015315A1 (en) 2006-07-12 2008-01-17 Frank Chang Novel Polymers

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
Cramer et al., Mechanism and Modeling of a Thiol-Ene Photopolymerization, Macromolecules, 2003, vol. 36, pp. 4631-4636.
Cramer et al., Photopolymerizations of Thiol-Ene Polymers without Photoinitiators, Macromolecules, 2002, vol. 35, pp. 5361-5365.
Cramer et al., Thiol-Ene Photopolymerization Mechanism and Rate Limiting Step Changes for Various Vinyl Functional Group Chemistries, Macromolecules, 2003, vol. 36, pp. 7964-7969.
Evans et al., Free-Radical Ring-Opening Polymerizatino of Cyclic Allylic Sulfides, Macromolecules, 1996, vol. 29, pp. 6983-6989.
Evans et al., Free-Radical Ring-Opening Polymerization of Cyclic Allylic Sulfides. 2. Effect of Substituents on Seven- and Eight-Membered Ring Low Shrink Monomers, Macromolecules, 2000, vol. 33, pp. 6722-6731.
Evans et al., New Free-Radical Ring-Opening Acrylate Monomers, Macromolecules, 1994, vol. 27, pp. 7935-7937.
Naciri et al., Molecular Structure and Pretilt Control of Photodimerized-Monolayers (PDML), Journal of Materials Chemistry, 2004, vol. 14, pp. 3468-3473.
Norbornene Technical Data Sheet, 2002, 6 pages.
Okay et al., Molecular Weight Development During Thiol-Ene Photopolymerizations, Macromolcules, 2005, vol. 38, pp. 4501-4511.
Scott et al., Photoinduced Plasticity in Cross-Linked Polymers, Science, 2005, vol. 308, pp. 1615-1617.

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8609745B2 (en) 2006-12-13 2013-12-17 Novartis Ag Production of ophthalmic devices based on photo-induced step growth polymerization
US8357771B2 (en) 2006-12-13 2013-01-22 Novartis Ag Production of ophthalmic devices based on photo-induced step growth polymerization
US9096025B2 (en) 2008-07-21 2015-08-04 Novartis Ag Silicone hydrogel lenses with convertible comfort agents
US9907741B2 (en) 2008-11-28 2018-03-06 Luromed Llc Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
US9345778B2 (en) 2008-11-28 2016-05-24 Luromed Llc Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
US9149534B2 (en) 2008-11-28 2015-10-06 Luromed Llc Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
US8679470B2 (en) 2008-11-28 2014-03-25 Luromed Llc Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
US8940281B2 (en) 2008-11-28 2015-01-27 Luromed Llc Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
US20100135935A1 (en) * 2008-11-28 2010-06-03 Leshchiner Adelya K Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
US20110076243A1 (en) * 2009-09-28 2011-03-31 Leshchiner Adelya K Modified hydrophilic polymers containing hydrophobic groups
US8247390B2 (en) * 2009-09-28 2012-08-21 Luromed Llc Modified hydrophilic polymers containing hydrophobic groups
US20110133350A1 (en) * 2009-12-07 2011-06-09 Yongxing Qiu Methods for increasing the ion permeability of contact lenses
US8883051B2 (en) 2009-12-07 2014-11-11 Novartis Ag Methods for increasing the ion permeability of contact lenses
US9005492B2 (en) 2009-12-14 2015-04-14 Novartis Ag Methods for making silicone hydrogel lenses from water-based lens formulations
US20110140292A1 (en) * 2009-12-14 2011-06-16 Frank Chang Methods for making silicone hydrogel lenses from water-based lens formulations
US20130341811A1 (en) * 2012-06-25 2013-12-26 Johnson & Johnson Vision Care, Inc. Lens comprising low and high molecular weight polyamides
US9395468B2 (en) 2012-08-27 2016-07-19 Ocular Dynamics, Llc Contact lens with a hydrophilic layer
US9315669B2 (en) 2013-09-30 2016-04-19 Novartis Ag Method for making UV-absorbing ophthalmic lenses
US9568645B2 (en) 2013-09-30 2017-02-14 Novartis Ag Silicone hydrogel lenses with relatively-long thermal stability
US9919456B2 (en) * 2013-10-31 2018-03-20 Novartis Ag Method for producing ophthalmic lenses
US20150115485A1 (en) * 2013-10-31 2015-04-30 Novartis Ag Method for producing ophthalmic lenses
WO2015066255A1 (en) 2013-10-31 2015-05-07 Novartis Ag Method for producing ophthalmic lenses
US9310627B2 (en) 2013-11-15 2016-04-12 Ocular Dynamics, Llc Contact lens with a hydrophilic layer
US9802339B2 (en) 2013-12-13 2017-10-31 Novartis Ag Method for making contact lenses
US9684095B2 (en) 2014-04-25 2017-06-20 Novartis Ag Hydrophilized carbosiloxane vinylic monomers
WO2016048853A1 (en) 2014-09-26 2016-03-31 Novartis Ag Polymerizable polysiloxanes with hydrophilic substituents
US9637582B2 (en) 2014-09-26 2017-05-02 Novartis Ag Polymerizable polysiloxanes with hydrophilic substituents
US9829723B2 (en) 2015-12-03 2017-11-28 Novartis Ag Contact lens packaging solutions
WO2017093834A1 (en) 2015-12-03 2017-06-08 Novartis Ag Contact lens packaging solutions
WO2017103790A1 (en) 2015-12-15 2017-06-22 Novartis Ag Hydrophilized polydiorganosiloxane vinylic crosslinkers and uses thereof
WO2017103792A1 (en) 2015-12-15 2017-06-22 Novartis Ag Amphiphilic branched polydiorganosiloxane macromers

Also Published As

Publication number Publication date Type
CA2644791A1 (en) 2007-12-21 application
EP2029349B1 (en) 2010-09-01 grant
EP2029349A2 (en) 2009-03-04 application
JP5064498B2 (en) 2012-10-31 grant
DE602007008891D1 (en) 2010-10-14 grant
WO2007146137A3 (en) 2008-02-14 application
JP2009540369A (en) 2009-11-19 application
WO2007146137A2 (en) 2007-12-21 application
US20080174035A1 (en) 2008-07-24 application
CA2644791C (en) 2013-11-26 grant

Similar Documents

Publication Publication Date Title
US20050218536A1 (en) Colored ink for pad transfer printing of silicone hydrogel lenses
US20070138692A1 (en) Process for forming clear, wettable silicone hydrogel articles
US20090057164A1 (en) Contact lens packaging solutions
US20050013842A1 (en) Antimicrobial medical devices
US20080234457A1 (en) Silicone-containing prepolymers with dangling hydrophilic polymer chains
US20100120938A1 (en) Polysiloxane copolymers with terminal hydrophilic polymer chains
EP1818692A2 (en) Release aids for releasing silicone hydrogen ophthalmic lenses
US20070037897A1 (en) Method for making contact lenses
US20110063567A1 (en) Prepolymers suitable for making ultra-violet absorbing contact lenses
US20080231798A1 (en) Prepolymers with dangling polysiloxane-containing polymer chains
US20020137811A1 (en) Tinted, high Dk ophthalmic molding and a method for making same
US20110102736A1 (en) Silicone hydrogel lens with a grafted hydrophilic coating
US20100298446A1 (en) Actinically-crosslinkable siloxane-containing copolymers
US20070132949A1 (en) Method for preparing silicone hydrogels
US20110134387A1 (en) Silicone hydrogel lens with a covalently attached coating
US20100296049A1 (en) Actinically-crosslinkable siloxane-containing copolymers
US8163206B2 (en) Method for making silicone hydrogel contact lenses
US20100140114A1 (en) Ophthalmic devices for delivery of hydrophobic comfort agents
US20120026458A1 (en) Silicone hydrogel lenses with water-rich surfaces
US20070037898A1 (en) Silicone hydrogels
US20080143958A1 (en) Production of ophthalmic devices based on photo-induced step growth polymerization
US20090230575A1 (en) Method for cast molding contact lenses
US7213918B2 (en) Method for making colored silicone hydrogel contact lenses
US20090160074A1 (en) Method for making contact lenses
US20070229758A1 (en) Method for applying a coating onto a silicone hydrogel lens

Legal Events

Date Code Title Description
AS Assignment

Owner name: NOVARTIS AG, SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WINTERTON, LYNN COOK;REEL/FRAME:019452/0296

Effective date: 20070523

FPAY Fee payment

Year of fee payment: 4